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The national burden of Neonatal Abstinence Syndrome on individuals, families, 
and the healthcare system has reached epidemic proportion. The rising incidence of 
Neonatal Abstinence Syndrome significantly impacts healthcare utilization and costs due 
to increases in Neonatal Intensive Care Unit admissions and length of hospitalization, to 
the possible detriment of maternal-infant bonding. Because nonpharmacologic nursing 
care is not complicated by the potentially harmful side effects of pharmacological 
treatment, it should be considered the standard of care for opioid-exposed infants; 
therefore, a comprehensive understanding of the barriers and enablers to nurses’ 
implementation of nonpharmacological interventions for infants with Neonatal 
Abstinence Syndrome is needed.  
This dissertation examines the benefits and factors associated with breastfeeding 
(a key nonpharmacological intervention) for the opioid-dependent maternal-infant dyad, 
factors associated with influencing healthcare providers’ behaviors in the care of infants 
with Neonatal Abstinence Syndrome, and barriers and enablers to nurses’ implementation 
of nonpharmacological interventions for infants with Neonatal Abstinence Syndrome. 
Findings from this study will inform the development of programs to improve nurses’ 
implementation of nonpharmacological interventions and health and utilization outcomes 
in infants with Neonatal Abstinence Syndrome. 
Keywords 
Neonatal Abstinence Syndrome; neonatal withdrawal; Theoretical Domains Framework; 
nonpharmacological interventions; nursing interventions; length of stay 
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 The burden of Neonatal Abstinence Syndrome (NAS) on individuals, families, 
and the healthcare system has reached epidemic proportions. NAS, a drug withdrawal 
syndrome that most frequently occurs in infants with intrauterine exposure to opioids (1), 
results in prolonged hospitalization and a wide array of deleterious symptoms requiring 
extensive pharmacological treatment (2). In 2016, the overall incidence rate of NAS was 
6.7 per 1000 in-hospital births with hospital costs totaling $572.7 million (1). The 
majority of hospital costs (83%) were covered by Medicaid, indicating a disproportionate 
financial burden on state and federal budgets (1). 
 Admissions of infants with NAS to neonatal intensive care units (NICUs) 
increased from 7 per 1000 admissions in 2004 to 27 per 1000 admissions in 2013, with an 
associated increase in the average length of stay (LOS) from 13 to 19 days (3). In 2012, 
the average LOS for infants with NAS was 17 days and if pharmacologic treatment was 
required, the average LOS increased to 23 days (4). Prolonged hospitalization separates 
the mother from her infant during a critical time and impairs bonding, which is associated 
with negative developmental and behavioral outcomes (5). 
 On a national level, this epidemic significantly impacts healthcare systems, as 
studies have shown intrauterine exposure to opioids is associated with intrauterine growth 
restriction, congenital anomalies, prematurity, low birth weight, and NAS (6). In the US, 
the federal government introduced the 2015 Protecting Our Infants Act (S.799), with the 
objectives of improving NAS surveillance programs, addressing research gaps, and 
implementing effective measures for education, prevention, and treatment (7). The US 
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Department of Health and Human Services determined that gaps in research were related 
to “the most appropriate treatment and management of infants with NAS” (S.799). In 
response to this gap in research and to address the objectives of the Protecting Our 
Infants Act, the dissertation study presented in this compendium was designed to inform 
the development of programs to improve nurses’ implementation of nonpharmacological 
interventions and health and utilization outcomes in infants with NAS. 
 The implementation of standardized protocols for NAS management is associated 
with decreased LOS and hospital costs (8,9). The American Academy of Pediatrics 
(AAP) Committee on Drugs recommends the establishment of an evidence-based 
protocol guiding the assessment and management of infants diagnosed with NAS or those 
at high risk for withdrawal (2). Although current NAS screening, assessment, and 
treatment methods have limitations, the AAP committee recommends all clinicians be 
educated on the application of validated withdrawal assessment tools (2). However, the 
assessment and care management of infants with NAS varies widely among hospitals in 
the US, and existing protocols have been based on minimal empirical data (10). In a 
recent survey of accredited US neonatology fellowship programs, only 55% had 
implemented a written NAS management protocol, and only 69% used a published 
abstinence scoring system to determine the severity of withdrawal and inform the 
treatment provided (11). In addition, new research findings are often not disseminated to 
clinicians and therefore not implemented into practice (12). As a result, infants with NAS 
may not receive the recommended course of treatment and may instead receive 
unnecessary, ineffective, or even harmful therapies (12).  
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 Experts recommend treating the maternal-infant dyad as the standard of care as 
opposed to treating the infant with NAS alone (13-15). The nurse’s role is to properly 
assess and interpret the infant’s behaviors, determine how the mother understands and 
responds to her infant, and tailor interventions that help the mother care for her infant 
(16). However, even though nurses are well-positioned to have a positive influence on the 
maternal-infant dyad, they often exhibit judgmental behaviors because of negative 
stereotypes about opioid-dependent mothers (16). In addition, maternal feelings of fear, 
guilt, and shame related to drug use often limit the mother’s ability to have honest 
conversations with nurses (17). Further, nurses often lack the required knowledge to 
provide optimal care to the maternal-infant dyad, a barrier that may also limit the 
development of nurse-mother relationships (18). To address these challenges, nurses 
providing care for infants with NAS should receive specialized training that addresses all 
facets of nursing care, including detailed information on adult addiction and drug use 
during pregnancy, maternal attachment behaviors, encouragement of appropriate 
maternal behavior, and breastfeeding when appropriate (17,19). This dissertation study is 
significant because findings can inform the development and implementation of 
specialized programs for nonpharmacological nursing interventions to improve outcomes 
for the maternal-infant dyad, such as supporting breastfeeding when appropriate, caring 
for the maternal-infant dyad, and promoting nurse-mother relationships (16,19,20). 
Specific Aims 
 This dissertation examines nurses’ perceptions of barriers and enablers to 
implementation of nonpharmacological interventions for infants with NAS. The three 
4 
 
manuscripts included in this study identify strategies for nurses to implement best 
practice standards, nonpharmacological interventions, and clinical practice guidelines 
(CPGs) in the care of infants with NAS and their families. 
Aim 1: Examine benefits and factors associated with breastfeeding (a key 
nonpharmacological intervention) for the opioid-dependent maternal -infant dyad. 
 The first manuscript is a scoping review to explore what is known about the 
benefits of maternal breastmilk for the opioid-dependent maternal-infant dyad and to 
evaluate factors related to breastfeeding implementation by opioid-dependent maternal-
infant dyads guided by the SEM. The key findings from this scoping review identified the 
importance of treating the infant with NAS as part of the maternal-infant dyad. Despite 
recommendations for mothers in treatment to breastfeed their infants, many barriers 
prevent mothers of infants with NAS from breastfeeding. Further, intentional, multi-level 
interventions aimed at creating a more secure, compassionate, and comfortable 
environment for the NAS maternal-infant dyad enhances outcomes for both mother and 
infant. 
Aim 2: Explore factors associated with influencing healthcare providers’ behaviors in 
the care of infants with NAS. 
 The second manuscript is an integrative review, guided by the Whittemore and 
Knafl methodology (21), on the current knowledge of the individual and contextual 
factors that influence healthcare providers’ behaviors in implementing 
nonpharmacological interventions to decrease LOS for infants with NAS through the lens 
of the TDF. Key findings included: implementing evidence-based CPGs, which have 
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been shown to increase identification of infants with NAS, decrease NAS severity using 
the Finnegan scoring tool, and decrease LOS; providing specialized training for 
healthcare providers; including parents as integral care team members; utilizing 
standardized withdrawal scoring tools; and including multidisciplinary care team 
members in the care of infants with NAS to enhance overall outcomes for infants and 
their families. In addition, the findings from the integrative review identified key 
influential TDF domains which were further explored in the dissertation study. 
Aim 3: Investigate barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with NAS. 
 The third and final manuscript is a convergent parallel mixed methods study, 
conducted through the lens of the TDF, which identified and prioritized barriers and 
enablers of nurses’ implementation of nonpharmacological interventions for infants with 
NAS. The findings from this study will inform the development of programs to improve 
nurses’ implementation of nonpharmacological interventions in the care of this 
vulnerable and rapidly growing patient population: the infant diagnosed with NAS. 
Innovation 
 This parallel convergent mixed methods dissertation study exhibits two primary 
innovations. It is the first to investigate barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with NAS. A comprehensive representation 
of nurses’ perspectives on the barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with NAS was obtained through 
administration of a tailored Determinants of Implementation Behavior Questionnaire 
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(DIBQ-NAS) to members of the National Association of Neonatal Nurses (NANN) and 
semi-structured interviews with nurses. A second source of innovation is that this study 
was the first to utilize the Theoretical Domains Framework (TDF) to guide the 
exploration of nurses’ implementation of nonpharmacological interventions for infants 
with NAS. The TDF provided a structure for assessing and evaluating the factors that 
affect the behavior of healthcare providers and the implementation of evidence-based 
practice (22, 23).  
Theoretical Framework 
 The developers of the TDF identified 33 theories and 128 key theoretical 
constructs associated with behavior change and synthesized them into one framework 
that can be used to guide theoretical assessment of implementation problems, as well as 
professional and other health-related behaviors as a basis for intervention development 
(22). Knowledge, Skills, and Social/Professional Role and Identity are the domains with 
greatest influence on providers’ implementation of nonpharmacological interventions to 
decrease the LOS for infants with NAS (24). The Knowledge domain of the TDF includes 
the following constructs: knowledge, knowledge about condition/scientific rationale, 
schemas + mindsets + illness representations, and procedural knowledge (25). The Skills 
domain of the TDF includes the following constructs: skills, competence/ability/skill, 
assessment, practice/skills development, interpersonal skills, and coping strategies (25). 
The Social/Professional Role and Identity domain of the TDF includes the following 
constructs: identity, professional identity/boundaries, role, group/social identity, 
social/group norms, and alienation/organizational commitment (25). In the integrative 
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review, the primary themes identified within these domains included: knowledge of NAS 
and AAP (American Academy of Pediatrics) recommendations regarding the 
management of NAS, nursing competence (assessment skills and effective utilization of 
the Finnegan scoring tool), development of interpersonal relationships with parents 
within professional boundaries, establishment of role within a multidisciplinary team, and 
leadership in the management and care of infants with NAS. In addition to the 
Knowledge, Skills, and Social/Professional Role and Identity domains, this study 
investigated other influential contextual and environmental domains, such as Beliefs 
about Capabilities, Environmental Context and Resources, Organization, and Emotion, 
related to infants with NAS and the nurses who care for the NAS maternal-infant dyad.  
Research Approach 
 In preparation for this dissertation study, a scoping review was conducted to 
explore benefits of maternal breastmilk and to evaluate factors related to breastfeeding 
implementation by opioid-dependent maternal-infant dyads guided by the Social 
Ecological Model (SEM). In addition, a small pilot study was conducted to explore 
nurses’ and other key interdisciplinary team members’ perceptions of the treatment plan 
and care provided for infants with NAS. The findings from the pilot study were used to 
inform and further refine the research design and methods for this dissertation study.  
 Further, an integrative review (24), guided by the constructs of the TDF, was 
completed which focused on factors influencing healthcare providers’ behaviors in the 
care of infants with NAS. Knowledge, Skills, and Social/Professional Role and Identity 
were identified as being the most influential domains relevant to modifying healthcare 
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providers’ behaviors surrounding implementation of nonpharmacological interventions 
aimed at decreasing the LOS for infants with NAS. 
 Finally, the dissertation study conducted through the lens of the TDF identified 
and prioritized barriers and enablers of nurses’ implementation of nonpharmacological 
interventions for infants with NAS. The findings from this study will inform the 
development of programs to improve nurses’ implementation of nonpharmacological 
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A Scoping Review of the Benefits of Breastmilk for the  
Methadone Dependent Maternal-Infant Dyad 
Abstract 
Due to a significant increase in the number of infants diagnosed with neonatal abstinence 
syndrome, it is important to develop a more comprehensive understanding of the health 
implications of breastmilk provided by the mother. Therefore, the purpose of this scoping 
review of literature is to explore what is known about the benefits of maternal breastmilk 
for the opioid-dependent maternal-infant dyad, and to evaluate factors related to 
breastfeeding implementation by opioid-dependent maternal-infant dyads guided by the 
Social Ecological Model. The Social Ecological Model for health promotion is utilized as 
the theoretical framework for this study because it supports the concept of developing 
health promotion interventions that focus on the person and environment. Results of this 
review may provide knowledge to inform future interventions and assist in the 
development and implementation of best practice standards, clinical practice guidelines, 
and protocols to mitigate barriers that prevent opioid-dependent mothers from 
breastfeeding. The need for extensive support must be emphasized to ensure high 
initiation rates and long duration of breastfeeding, when appropriate, to improve the care 
of this vulnerable and rapidly-growing patient population: the neonatal abstinence 
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Introduction and Background 
The number of expectant mothers using opiates rose nearly five-fold from 2000 to 
2009 (Patrick et al., 2012). Among neonates with in-utero exposure to opioids, an 
estimated 60%-90% experience drug withdrawal, a condition defined as Neonatal 
Abstinence Syndrome (NAS) (Ebner et al., 2007). NAS is characterized by a wide array 
of signs and symptoms, including increased irritability, hypertonia, tremors, feeding 
intolerance, emesis, watery stools, seizures, and respiratory distress, often requiring 
prolonged hospitalization and extensive pharmacological therapy (American Academy of 
Pediatrics Committee on Drugs, 1998). The use of pharmacological therapies is supported 
by an extensive body of research that indicates opiates should be first-line treatment for 
infants with NAS (American Academy of Pediatrics Committee on Drugs, 1998). 
Currently, methadone maintenance therapy is the standard of care for mothers dependent 
on opiates during the perinatal period and the only pharmaceutical treatment 
recommended in the United States (Jarvis & Schnoll, 1994; National Consensus 
Development Panel on Effective Medical Treatment of Opiate Addiction, 1998). 
Methadone maintenance therapy has successfully decreased the use of other opiates and 
illicit drugs and the risk of infant loss, while increasing utilization of prenatal care and 
substance abuse counseling (Jones et al., 2010).  
Although mothers undergoing methadone maintenance therapy have been 
discouraged from breastfeeding in the past if the maternal methadone dose was above 
20mg/day, the American Academy of Pediatrics (in 2001 and 2013) no longer lists 
methadone at any dose as a breastfeeding contraindication. The nutritional and 
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immunologic benefits of breastmilk for optimal health and development for all infants are 
well established (World Health Organization, n.d.). And while there is limited research 
on how maternal breastmilk augments pharmacologic treatment in infants with NAS, 
studies suggest ingestion of maternal breastmilk may be an independent predictor of 
favorable response to methadone therapy for infants with NAS (Isemann, Meinzen-Derr, 
& Akinbi, 2010; Welle-Strand et al., 2013; O’Connor, Collett, Alto, & O’Brien, 2013). In 
fact, breastfeeding has been shown to act as an analgesic for infants and is an established 
method for soothing agitated infants, thus potentially improving withdrawal symptoms in 
infants with NAS (Gray, Miller, Philipp, & Blass, 2002).  
Some research findings have shown that women who have breastfed and those 
who have breastfed for longer periods of time have experienced less postpartum 
depression (U.S. Department of Health and Human Services [DHHS], 2011). For women 
with a history of substance abuse and prior psychiatric comorbidities, such as anxiety, 
depression, bipolar disorder, or attention-deficit/hyperactivity disorder, a reduction in the 
risk of postpartum depression may be critical (Pritham, 2013) because the connection 
between opioid dependence and co-occurring psychiatric symptoms in pregnant women 
who receive methadone maintenance therapy is significant (Benningfield et al., 2010).  
The immediate effects of skin-to-skin contact and breastfeeding on maternal 
bonding may deter maternal substance abuse relapse and enhance infant development 
(Pritham, 2013). Early skin-to-skin contact after birth encourages breastfeeding and has 
positive effects on maternal feelings toward their infant (AAP, 2012). Skin-to-skin 
contact and breastfeeding stimulate the release of oxytocin in the mother’s brain, which 
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elicits maternal parenting behaviors (Moore, Anderson, & Bergman, 2007; Nagasawa, 
Okabe, Mogi, & Kikusui, 2012). When oxytocin is released, pain, stress, and anxiety 
behaviors are lessened, which allows the mother to be more attentive to her infant 
(Nagasawa et al., 2012). In addition, the bonding that develops as a result of skin-to-skin 
contact and breastfeeding provides the encouragement to continue breastfeeding, thereby 
establishing lifelong health benefits for the mother and infant (Pritham, 2013).  
Despite all the benefits breastfeeding offers to this population, breastfeeding 
initiation among women in methadone treatment programs is low, with reports ranging 
from 24%-46%, compared with the national initiation rate of 77% (Wachman, Byun, & 
Philipp, 2010; CDC, 2012). In addition, lactation among women in methadone treatment 
programs (Jansson, 2009) and maternal perceptions of the decision to breastfeed the 
infant with NAS have been understudied. Due to a significant increase in the number of 
infants diagnosed with NAS, it is important to develop a more comprehensive 
understanding of the health implications of breastmilk provided by the mother. Therefore, 
the purpose of this scoping review of literature is: 
1. To explore what is known about the benefits of maternal 
breastmilk for the opioid-dependent maternal-infant dyad. 
2. To evaluate factors related to breastfeeding implementation by 
opioid-dependent maternal-infant dyads guided by the Social 




The Social Ecological Model (SEM) for health promotion is utilized as the 
theoretical framework for this study because it supports the concept of developing health 
promotion interventions that focus on the person and environment (McLeroy, Steckler, 
Bibeau, & Glanz, 1988). The SEM model posits that “appropriate changes in the social 
environment will produce changes in individuals, and that the support of individuals in 
the population is essential for implementing environmental changes” (McLeroy et al., 
1988, p. 351). The SEM intent is to mitigate unhealthy behaviors by aiming interventions 
at several determining factors: intrapersonal (characteristics of individual, attitudes, and 
behaviors); interpersonal (social support system including family, work associates and 
friends); institutional (social institutions with organizational structure); community 
(relationships among organizations, and informal networks within defined boundaries); 
and public policy (local, state, national laws and policies) (McLeroy et al., 1988). 
 Figure 1 represents the relationship between the maternal-infant dyad and the five 
levels of influence of the SEM. Applying the SEM is the first step in learning the best 
methods for changing the environment to improve health. The intrapersonal factor 
corresponds to the bond between mother and child, maternal self-efficacy, infant security, 
and perceived maternal stigma. The interpersonal factor relates to maternal support, 
family relationships, relationships developed through employment and/or education, and 
relationships with healthcare providers. The institutional factor corresponds to the 
maternal methadone inpatient treatment program, the hospital nursery where the infant is 
admitted (while receiving care for Neonatal Abstinence Syndrome), and maternal 
hospitalization. The community factor relates to the support the mother receives from 
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community resources, such as, WIC (Women, Infants, and Children: Food and Nutrition 
Service), prenatal care, and transportation services. The public policy factor corresponds 
to policies that are aimed at supporting vulnerable populations (mother-infant dyad), such 
as Medicare and Medicaid. Many governmental policies and programs have been created 
to encourage breastfeeding, such as the implementation of the Baby Friendly Hospital 
Initiative (BFHI) and the Federal Nursing Mother’s Program. Effective multi-level 
interventions should aim to create conditions that allow the parent(s) to provide a safe, 






 A scoping study is utilized when a specific research question has not been 
identified and the intent is to review broader topics, regardless of study design (Arskey & 
O’Malley, 2005). Arskey and O’Malley (2005) developed a specific approach to increase 
reliability of findings and methodological rigor (Mays, Roberts, & Popay, 2001). This 
five-stage process was utilized in conducting this scoping study. The Arskey and 
O’Malley (2005) methodological framework includes establishing a research question; 
determining pertinent studies; refining the selection of literature; charting the data; and 
collating, summarizing and reporting the results.  
 During a consultation with a reference librarian at an academic medical center, 
the following electronic databases were determined to be the most appropriate for this 
scoping study:  Scopus, PubMed, and EBSCOhost (see table 1). Each database was 
searched utilizing the following terms: “Breastfeeding” and “Methadone.” 
Table 1 
Available databases on the EBSCOhost platform 
EBSCOhost databases 
CINAHL Complete; Academic Search Premier; Agricola; Alt HealthWatch; Newswires; Applied 
Science & Technology Full Text (H.W. Wilson); CINAHL Plus with Full Text; Computer Source; 
Criminal Justice Abstracts with Full Text; eBook Collection (EBSCOhost); Education Full Text 
(H.W. Wilson); ERIC; European Views of the Americas: 1493 to 1750; Fuente Académica; Funk & 
Wagnalls New World Encyclopedia; GreenFILE; Health Source - Consumer Edition; Health Source: 
Nursing/Academic Edition; History Reference Center; Library Literature & Information Science 
Index (H.W. Wilson); Library, Information Science & Technology Abstracts; MAS Ultra - School 
Edition; MasterFILE Premier; MEDLINE; Middle Search Plus; Military & Government Collection; 
Newspaper Source Plus; Primary Search; Professional Development Collection; PsycARTICLES; 
Psychology and Behavioral Sciences Collection; PsycINFO; Regional Business News; Religion and 
Philosophy Collection; Science Reference Center; Teacher Reference Center; TOPICsearch; 
Vocational and Career Collection; Web News; AHFS Consumer Medication Information; American 
Doctoral Dissertations, 1933 - 1955; eBook Academic Collection (EBSCOhost); Consumer Health 
Complete - EBSCOhost; 
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 The inclusion criteria for the articles were the following: the English language, 
peer reviewed journals, humans, and published between 2005 and 2019. The reference 
lists of selected articles were also examined for principal sources and additional pertinent 
articles. 
 During the first search of the electronic databases, 138 articles were retrieved. 
After citations were reviewed, 52 articles were determined to be duplicates and therefore 
removed. The remaining 86 articles’ abstracts were examined for relevance based on the 
inclusion and exclusion criteria. Research articles specific to the benefits of breastmilk 
for Neonatal Abstinence Syndrome infants and the maternal health benefits of 
breastfeeding were included. Articles that contained findings extraneous to infant and 
maternal health were excluded (n = 44). Of the remaining 42 full-text articles, 10 studies 
met the inclusion criteria for the study sample. 
 A PRIMSA flow diagram of this process was developed (Appendix A) (Moher, 
Liberati, Tetzlaff, & Altman, 2009) as The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement was utilized in selecting articles that 
were included in the study sample. In addition, a scoping review matrix (Appendix B) 
was created to organize the selected articles by author, date, study purpose, study design, 
level of evidence, setting, sample description, size, data collection methods, results, and 
limitations, therefore completing Stage 4 of Arskey and O’Malley’s methodological 
framework. The SEM was utilized to complete Stage 5 of the Arskey and O’Malley 




 The studies that met the inclusion and exclusion criteria (n = 10) were primarily 
conducted in substance abuse treatment centers and hospitals; one study utilized a 
qualitative, focus group design, one study utilized a three-part cohort design, six studies 
utilized retrospective chart reviews, and two studies utilized a systematic review. The 
studies utilized historical maternal and neonatal data, interviews, case note reviews, the 
Finnegan NAS scoring tool, and literature reviews as data collection methods. A majority 
of the peer-reviewed articles addressed the effects of feeding methods (specifically 
breastfeeding) on the severity of NAS, management and treatment of NAS, and the 
maternal experience of breastfeeding while receiving methadone treatment.  
Social Ecological Model 
 Although none of the selected studies utilized the SEM as the framework for the 
design, a majority of the studies specifically addressed the intrapersonal level of 
influence (n = 8), interpersonal level (n = 1), institutional level (n = 5), community level 
(n = 2), and public policy level (n = 2) (see table 2). None of the selected studies 





Study Purpose SEM Level SEM Influential 
Factors 
Abdel-
Latif et al., 
2006 
To assess the effects of 
breastmilk on the severity and 
outcome of NAS 
Intrapersonal Maternal-infant bond, 
maternal self-efficacy, 
& infant security  
Bagley et 
al., 2014 
To examine evidence for NAS 
tools, nonpharmacological 
interventions, & 
pharmacological management of 
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healthcare resources of infants 









& maternal stigma 
 
Community support 
services & outpatient 
clinic care 
Hodgson 
et al., 2012 
To explore the effect of a 
rooming-in protocol on the need 










within hospital setting 
Isemann et 
al., 2011 
To identify maternal and 
neonatal factors that impact 
response therapy for NAS 
Intrapersonal Maternal-infant bond, 
maternal self-efficacy, 
& infant security 
McQueen 
et al., 2011 
To determine whether NAS 
scores of infants exposed to 
methadone in-utero differed by 












breastfeeding to assist 






To review literature regarding 
the association of breastfeeding 
and NAS severity, need for 
pharmacological therapy, and 
length of stay 
Institutional Provision of education 
by healthcare providers 
in the hospital/nursery 
setting 
Wachman 
et al., 2010 
To determine breastfeeding rates 






















To examine the rate and duration 
of breastfeeding in a cohort of 
women in opioid maintenance 
therapy and the effect of 
breastfeeding on the incidence 








& infant security 
 
Provision of education 
by healthcare providers 




 Intrapersonal factors were found to have the most significant impact on the health 
outcomes of the mother and infant as they directly correspond to maternal-infant 
bonding, maternal self-efficacy, infant security, and maternal stigma. A majority of the 
studies focused primarily on the intrapersonal factors related to the initiation of 
breastfeeding in the opioid-dependent maternal-infant dyad.  
 Abdel-Latif et al. (2006) addressed the intrapersonal factor of the SEM, finding 
that mothers who elected to breastfeed were more likely to have received antenatal care, 
or to admit to less polydrug use, and were less likely to be identified to child welfare 
services as an at-risk parent, potentially enabling the mother to effectively soothe her 
infant thereby reducing the infant’s Finnegan withdrawal scores. Abdel-Latif et al. (2006) 
also found that fewer infants who received maternal breastmilk required pharmacologic 
treatment for withdrawal (52.9% versus 79%, p < .001) and the average time to withdraw 
occurred significantly later in infants who received maternal breastmilk compared with 
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those who received formula (10 days versus 3 days; p < .001). In addition, the amount of 
morphine administered for withdrawal was considerably lower in infants who received 
maternal breastmilk compared with those who received formula (Abdel-Latif et al., 
2006). The overall treatment duration was approximately 20 days less for infants who 
received maternal breastmilk (Abdel-Latif et al., 2006).  
 Bagley, Wachman, Holland, and Brogly (2014) found similar results in a 
systematic review. Their findings indicated that breastfed infants experienced an overall 
decrease in pharmacological treatment, length of pharmacological treatment (if required), 
NAS scores, and length of hospitalization. Dryden, Young, Hepburn, and Mactier (2009) 
determined that breastfeeding for 72 hours or greater was independently associated with 
decreasing the odds of the infant receiving pharmacological therapy for NAS by half. 
These findings are congruent with the results of a retrospective chart review conducted 
by Hodgson and Abrahams (2012) indicating that breastfeeding corresponded with a 
decrease of 79% (p < .001) in the odds of the infant receiving morphine therapy. In a 
retrospective review, Isemann, Meinzen-Derr, and Akinbi (2011) also determined 
maternal breastmilk feedings were associated with a shorter duration of pharmacological 
therapy and length of stay compared with formula fed infants (12.5 days versus 18.5 
days, p = 0.01). Similarly, in a cohort study Welle-Strand et al. (2013) found methadone-
exposed infants receiving breastmilk had a significantly lower incidence of NAS 
requiring pharmacological treatment (53%) than methadone-exposed infants not 
receiving breastmilk (80%). Welle-Strand et al. (2013) also found breastfed infants had a 
shorter duration of pharmacological therapy for NAS (28.6 days) compared with infants 
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who were not breastfed (46.7 days, p < 0.05). Reducing the length of stay for infants with 
NAS is critical because having the infant at home will enhance the maternal-infant bond 
while providing a more natural environment conducive to breastfeeding (McQueen et al., 
2011). 
 Despite these potential benefits, barriers to breastfeeding, including concern of 
transfer of hepatitis C to the infant through breastmilk may discourage mothers and 
providers from pursuing breastfeeding in this population. These barriers include 
perceived lack of time to breastfeed due to other responsibilities as well as concerns over 
not having “enough” breastmilk, of infant latching difficulty, and of an infant receiving 
too much methadone through the transfer of breastmilk (Demirci, Bogen, & Klionsky, 
2015). However, in their qualitative focus group study of seven pregnant women and four 
postpartum women receiving methadone maintenance therapy, Demirci et al. (2015) 
found that motivating factors may help to overcome these barriers. Motivating factors 
included the potential for enhanced maternal-infant bonding, perceived health benefits for 
mother and infant, and a means of mitigating infant discomfort related to NAS 
symptoms.  
Interpersonal Factors 
 Interpersonal factors correspond to maternal support, relationships with family 
members, relationships with work and school associates, and relationships with 
healthcare providers. These interpersonal factors have been shown to influence the 
implementation of breastfeeding in the vulnerable opioid-dependent maternal-infant 
dyad. Demirci et al. (2015) identified the mother’s own mother as a source of 
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breastfeeding knowledge and support; however, partners were perceived as sources of 
both support and anxiety regarding the decision to breastfeed. The participants in the 
study also identified peers as influential in their decision to breastfeed (Demirci et al., 
2015).  
Institutional Factors 
 Several studies addressed the institutional factors that directly correspond to 
methadone treatment programs and hospitals. In a systematic review, Bagley et al. (2014) 
addressed the institutional factor of the SEM by recommending that hospitals align 
clinical practices with standard protocols including the use of valid assessment measures, 
accepted pharmacologic treatment (morphine and methadone), and specific training for 
those delivering infant care. Evidence from two other studies suggests providing 
education addressing the benefits of breastfeeding along with practical instruction on the 
mechanics of breastfeeding may increase initiation rates (Pritham, 2013; Welle-Strand et 
al., 2013). Bagley et al. (2014) posited that mothers in treatment programs may have 
access to other healthcare services including counseling, infection screening, and fetal 
growth monitoring, thereby enhancing maternal and infant outcomes. However, mothers 
in treatment programs are also often required to attend group meetings, individual 
therapy sessions, and make daily trips to the treatment center for medication and drug 
testing, thereby limiting time with their infant (Wachman, Byun, & Philipp, 2010).  
Another potential method to improve breastfeeding initiation rates in this 
maternal-infant dyad is the development of a rooming-in program within the hospital 
setting. In a retrospective chart review, Hodgson and Abrahams (2012) examined a 
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rooming-in program to mitigate the need to treat infants for opiate withdrawal. Their 
findings suggest that rooming-in is a safe alternative to the current standard of care that 
separates mother and infant because it allows the mother to care for her infant and 
provides an environment conducive to breastfeeding thereby enhancing the maternal-
infant bond (Hodgson & Abrahams, 2012). 
Community Factors 
 Two studies addressed the community factors that directly correspond to WIC, 
prenatal care, transportation services, and civic organizations. Dryden et al. (2009) 
conducted a retrospective cohort study addressing the implications for healthcare and 
community resources dedicated to this vulnerable maternal-infant dyad. They posited that 
the majority of drug-misusing mothers electing not to breastfeed did so due to “deeply 
engrained social prejudices and not because of polydrug misuse” (Dryden et al., 2009, p. 
669). Dryden et al. (2009) found that outpatient follow-up care was often unutilized by 
this population due to their challenging and complex lifestyles. This finding suggests the 
need for providing community support services with increased efforts to facilitate 
interdisciplinary communication among service providers (Dryden et al., 2009).  
 The need for community support services is further emphasized by the findings of 
Demirci et al. (2016) as women in methadone therapy obtained breastfeeding information 
and misinformation within the health care community from WIC counselors and internet 




 While none of the studies in this scoping review specifically addressed the role of 
public policy as it related to the initiation of breastfeeding in the opioid-dependent 
maternal-infant dyad, many of the studies collectively suggested that agency policies 
regarding breastfeeding and methadone are needed to assist health care providers as they 
deliver evidence-based care to mothers in methadone treatment who desire to breastfeed. 
In addition, establishing breastfeeding policies for the opioid-dependent maternal-infant 
dyad may mitigate the potential for discrimination based on the mothers’ use of 
methadone (McQueen et al., 2011). 
 Wachman et al. (2010) discussed a hospital’s development of a multidisciplinary 
task force aimed at creating Breastfeeding and Illicit Drug Use Guidelines. The intent of 
the guidelines was to provide consistent care with an emphasis on the importance of 
maternal sobriety and the provision of all possible supports for mothers choosing to 
breastfeed. 
Discussion 
 The primary finding of this scoping review is that, when possible, and if not 
otherwise contraindicated, mothers who adhere to a supervised drug treatment program 
should be encouraged to breastfeed as long as the infant continues to gain weight (Abdel-
Latif et al., 2006; Bagley et al., 2014; Demirci, et al., 2015; Dryden et al., 2009; Isemann 
et al., 2011; McQueen et al., 2011; Pritham, 2013). Most of the studies included in this 
review show that breastfeeding has been associated with less severe NAS that presented 
later and required less frequent pharmacologic intervention, which resulted in fewer 
hospital days for the infant (Abdel-Latif et al., 2006; Bagley et al., 2014; Hodgson & 
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Abrahams, 2012; Isemann, et al., 2011; McQueen et al., 2011; Pritham, 2013; Welle-
Strand et al., 2013). Findings from published studies indicate that unnecessary 
pharmacologic treatment will prolong drug exposure and the duration of hospitalization 
to the possible detriment of maternal-infant bonding (Abdel-Latif et al., 2006; Hudak & 
Tan, 2012; McQueen et al., 2011; Pritham, 2013). The findings also indicate that 
breastfeeding provided optimal nutrition, promoted bonding, and empowered babies’ 
mothers to be effective parents (Legatte, 2008; Jambert-Gray et al., 2009; Jansson et al., 
2008; McQueen et al., 2011). In addition, Bagley et al. (2014) suggested that 
breastfeeding and allowing the maternal-infant dyad to “room-in” increased bonding and 
normalized the postpartum experience for mothers who may have felt vulnerable and 
stigmatized due to their history of opioid dependence.  
 Demirci et al. (2015) identified peers as influential in maternal breastfeeding 
decisions. This finding aligns with previous studies that suggest breastfeeding peer 
support programs can increase breastfeeding initiation rates, duration, and exclusivity, 
particularly for women who share unique breastfeeding concerns, such as those receiving 
methadone treatment (Britton, McCormick, Renfrew, Wade, & King, 2007; Chung, 
Raman, Trikalinos, Lau, & Ip, 2008; Fairbank et al., 2000). The most effective programs 
included breastfeeding training, health care provider involvement, early support, and peer 
assistants who shared a similar socio-economic background as the mothers they 




 The vulnerable population of the maternal-infant dyad has unique benefits to gain 
from breastfeeding due to the emotional, behavioral, and medical complications that 
often affect them; however, lactation among women in methadone treatment programs 
has been understudied (Jansson, 2009). Further, research dedicated to understanding 
maternal perceptions of the decision to breastfeed the NAS infant is lacking, as is 
research utilizing large-scale studies examining the effects of breastmilk on the severity 
of NAS as determined by a quantitative withdrawal scale (Abdel-Latif et al., 2006). Also, 
there is limited data on the inter-observer reliability of NAS assessment tools due to lack 
of a standardized approach (Bagley et al., 2014). As Demirci et al. (2015) suggest, future 
researchers should examine the feasibility and effectiveness of peer-based lactation 
support within methadone treatment centers and hospitals caring for infants with NAS. 
Isemann et al. (2011) argue that studies are needed to identify infants at risk for rebound 
NAS, including correlation with serum (methadone) concentrations in breastmilk. 
Finally, in future studies researchers should examine health care providers’ perceptions 
regarding breastfeeding and mothers in methadone treatment programs. 
Limitations 
 This scoping review provides a general overview of the available literature related 
to the benefits of breastmilk for the opioid-dependent maternal-infant dyad and factors 
related to breastfeeding implementation as guided by the SEM. Due to specific inclusion 
and exclusion criteria, this scoping review is not inclusive of all available literature 
related to this study topic. Also, a second researcher was not available to assist with the 
literature review process and mitigate researcher bias as recommended by Arksey and 
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O’Malley (2005). Finally, due to the utilization of specific search terms in the initial 
inquiry, additional articles related to the study topic may not have been discovered during 
this scoping review. 
Conclusions 
As illustrated by the evidence included within this review, it is important to 
consider the infant with NAS as part of a maternal-infant dyad as treatment for the infant 
does not occur in isolation from the mother. Despite the recommendations for mothers in 
treatment to breastfeed their infants, many barriers exist that prevent these mothers from 
breastfeeding, including inconsistent advice from health care providers; lack of clear 
guidelines; feeding problems (related to NAS); lengthy hospital stays that prohibit 
maternal-infant bonding; and issues such as low self-esteem, lack of knowledge, or 
feelings of maternal guilt (Dryden et al., 2009; McQueen et al., 2011; Jansson, Velez, & 
Harrow, 2004). Health care providers must understand current guidelines for 
breastfeeding among mothers in methadone treatment and offer these women 
nondiscriminatory and supportive counsel regarding common breastfeeding barriers and 
maternal concerns (Demirci et al., 2014). The need for extensive support must be 
emphasized to ensure high initiation rates and long duration of breastfeeding, when 
appropriate, for the benefit of the maternal-infant dyad. There is a critical need for more 
research concerning the effect of breastfeeding on infants with NAS, particularly studies 
that focus on the mother’s perception of the decision to breastfeed her infant. In addition, 
intentional, multi-level interventions aimed at creating a more secure, compassionate, and 
comfortable environment for the maternal-infant dyad will likely enhance outcomes for 
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both mother and infant. Due to the significant increase in infants diagnosed with NAS, 
those who care for these infants should utilize a standardized, objective, and validated 
tool to guide the treatment of NAS. These strategies will ensure consistent, quality care 
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Factors Influencing Healthcare Providers’ Behaviors in the Care of Infants with Neonatal 
Abstinence Syndrome (NAS):  An Integrative Review 
Abstract 
Due to a significant increase in the number of infants diagnosed with neonatal abstinence 
syndrome and the lengthy hospitalization often required for their pharmacologic 
treatment, a comprehensive understanding of the factors that influence healthcare 
providers’ behaviors in implementing nonpharmacological interventions for infants with 
neonatal abstinence syndrome is needed. The Whittemore and Knafl methodology guided 
an integrative review of literature on the current knowledge of the individual and 
contextual factors that influence healthcare providers’ behaviors in implementing 
nonpharmacological interventions that decrease the length of stay for infants with 
neonatal abstinence syndrome through the lens of the Theoretical Domains Framework. 
Results of this review may provide knowledge to inform future interventions and assist in 
the development and implementation of best practice standards, clinical practice 
guidelines, and protocols to improve the care of this vulnerable and rapidly-growing 
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Author, Date Study Purpose Study Design Setting Sample Description, Size Data Collection Methods Results
Asti et al, 2015
A multidisciplinary 
NAS task force was 
created to implement 
a standardized 
treatment protocol, 
discuss the strengths 
and weaknesses of 











Columbus, Ohio 92 infants Neonatal medical record data
Reliable monitoring of 
symptoms and the 




LOS from 36 days to 18 
days. One of the most 
effective 
interventions that 
impacted the LOS was 
the development of a 
staff NAS education 
program.
Casper et al, 2014
A thorough review 





development of a 
nursing CGP for 









56-bed level IV NICU, employing more 
than 170 RNs with staff experience 
ranging from new graduate to over 30 
years.
The CPG-update initiative included an 
evaluation of the literature regarding 
nurse-driven interventions to support a 
practice change that promotes 
evidence-based care practices for 
infants with NAS.
CPGs provide nurses 
with clear direction 
when caring for their 
patients. The 
guidelines are 
designed to reduce 
the withdrawal 
syptoms and 
discomfort of the 
fragile newborn and 
to nurture the 
maternal-infant dyad.
Grossman et al, 2017
An initiative to 
improve the quality of 




Yale New Haven 
Children's 
Hospital 287 Infants
The outcome measures included ALOS, 
morphine use, and hospital costs using 
statistical process control charts.
Interventions focused 
on nonpharmacologic 
therapies and a 
simplified approach to 
assessment for infants 
exposed to 
methadone in utero 
led to both substantial 
and sustained 
decreased in ALOS, 
the proportion of 
infants treated with 
morphine, and 
hospital costs with no 
adverse events.
Murphy-Oikonen et al, 
2012
To evaluate the 
effectiveness of a CPG 
on increasing 
identification of 
neonates with NAS 
symptoms based on a 
toxicology screening 
protocol, decreasing 






hospital in a mid-
size Canadian 
city
A final sample of 90 neonates 
demonstrating NAS symptoms were 
included in this study; 20 in the pre-
intervention group, and 70 in the post-
intervention group
Retrospective cohort comparison using 
hospital record data for neonates
There was a significant 
decrease in the 
overall average NAS 
score and in the 
number of measures 
taken over time 
between the two 
groups. Similarly, the 
change in CPG led to a 

















Author, Date Study Purpose Study Design Setting Sample Description, Size Data Collection Methods Results
Nelson, 2016
The purpose of the 
focused ethnography 
was to desribe the 
culture of care and 
nonpharmacologic 
nursing interventions 
performed by NICU 




A 44-bed NICU at 
a children's 
hospital in the 
southeastern US 12 full-time nurses Observation and interviewing
Results described the 
culture of care 
provided to infants 
with NAS by NICU 
nurses as evidenced 
by six themes: learn 
the baby, core team 
relationships, role 
satisfaction, grief, 
making a difference, 
and education and 
care of the mother.
Patrick et al, 2016






infants with NAS. The 
objective was to 















Audit data were collected by each 
center and reported to VON through 
the use of an online data portal. 
Hospital standardization was measured 
through serial assessment of hospital 
policies.
Of the participating 
centers, the mean 
number of NAS-
focused guidelines 
increased from 3.7 to 
5.1, with 
improvements in all 
domains. Also, LOT 
decreased from 16 to 
15 days and LOS 
decreased from 21 to 
19 days.




developed using a 
stepwise continuous 
quality improvement 
(CQI) approach with 
the goal of 
standardizing care 






Hospital is a 152-
bed hospital 
dedicated to the 
care of children 
with a 60 bed 




Retrospective data analysis with 
outcome variables of total LOS days, 
number of days required to wean from 
opioids, and number of hospital days 
from opioid wean to discharge, and 
number of adjunct medications.
The weaning time 
from opioids 
remained stable 
throughout each CQI 
steps. The overall 
total NICU LOS was 
reduced by 10.35 days, 
and the the LOS after 
completing wean from 
opioids was reduced 
by 2.79 days. Use of 
adjunct medications 





A Mixed Methods Study to Investigate Barriers and Enablers to Nurses’ Implementation 
of Nonpharmacological Interventions for Infants with Neonatal Abstinence Syndrome 
(NAS) 
Abstract 
Background: The incidence of Neonatal Abstinence Syndrome has increased 
significantly as a result of the opioid epidemic. A lengthy hospitalization is often required 
to treat the infant’s withdrawal symptoms. A comprehensive understanding of factors that 
influence nurses’ implementation of nonpharmacological interventions for infants with 
Neonatal Abstinence Syndrome is needed. 
Purpose: To investigate barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with Neonatal Abstinence Syndrome 
through the lens of the Theoretical Domains Framework. 
Methods: A parallel convergent mixed methods study was conducted. Qualitative data 
were collected using semi-structured interviews and quantitative data were collected 
using a tailored Determinants of Implementation Behavior Questionnaire with neonatal 
nurses. Findings from the interviews and surveys were merged through joint review to 
compare and contrast themes. 
Results: Enablers and barriers to nurses’ implementation of nonpharmacological 
interventions included education, experience, ability to implement nonpharmacological 
interventions, parental participation, stigmatization, lack of managerial/organizational 
support, staffing ratios, internal and external resources, and stress. Knowledge, Skills, 
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Beliefs about Capabilities, Social/Professional Role and Identity, Organization, and 
Emotion of the Theoretical Domains Framework aligned with these themes. 
Implications for Practice: Findings from this study will inform the development of 
programs to improve nurses’ implementation of nonpharmacological interventions and 
health and utilization outcomes in infants with Neonatal Abstinence Syndrome. 
Implications for Research: Future work should focus on the development of programs 
to improve nurses’ implementation of nonpharmacological interventions, with specific 
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     Up to 90% of neonates with in-utero opioid exposure experience Neonatal Abstinence 
Syndrome (NAS),1 which results in deleterious symptoms and complications, prolonged 
hospitalization, and extensive pharmacological therapy.2 In the United States, NAS 
incidence increased 383% from 2000 to 2012.3 In 2012, infants with NAS were 
hospitalized an average of 16.9 days (vs. 2.1 days for healthy newborns), costing an 
estimated $1.5 billion; the majority of charges (81%) were paid by state Medicaid 
programs, reflecting the greater tendency of opiate-dependent mothers to be from lower 
income communities.4 Opiates (oral morphine, methadone) should be first-line 
pharmacological treatment for infants with NAS2; however, nonpharmacological nursing 
care is as critical as pharmacologic treatment in decreasing withdrawal symptoms. To 
date, no research has focused on the barriers and enablers to nurses’ implementation of 
nonpharmacological nursing interventions for this population.  
     Nonpharmacologic nursing interventions, refinement of nurses’ NAS assessment 
skills, and accurate scoring of NAS withdrawal symptoms significantly reduces the 
severity of withdrawal, length of treatment (LOT), and length of stay (LOS), and 
improves maternal and infant outcomes.5 In contrast, ineffective nursing interventions, 
inaccurate assessments, and insufficient utilization of abstinence scoring tools contribute 
to unnecessary pharmacologic treatment, which prolongs drug exposure and 
hospitalization to the possible detriment of maternal-infant bonding.6 
     Because nonpharmacologic nursing care is not complicated by the potentially harmful 
side effects of pharmacological treatment, it should be the standard of care for opioid-
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exposed infants.7 Examples of nonpharmacologic nursing interventions include 
swaddling, providing quiet and low-stimulation environments, rooming-in, skin-to-skin 
holding, breastfeeding (unless contraindicated), and infant positioning.8 Mitigating the 
clinical complications of NAS may improve withdrawal severity, LOT, LOS, cost 
associated with LOS, and behavioral outcomes including maternal attachment.9 The 
purpose of this parallel convergent mixed methods study was to investigate barriers and 
enablers to nurses’ implementation of nonpharmacological interventions for infants with 
NAS through the lens of the Theoretical Domains Framework (TDF).  
Theoretical Framework 
     The TDF provides a means to examine factors that influence healthcare providers’ 
behavior related to the implementation of evidence-based practice and interventions in 
clinical practice.10 The TDF succinctly synthesizes various behavior change theories (33 
theories and 128 primary theoretical constructs) into one framework for multidisciplinary 
use.10 The TDF consists of 14 domains of theoretical constructs: ‘Knowledge,’ ‘Skills,’ 
‘Social/Professional Role and Identity,’ ‘Beliefs about Capabilities,’ ‘Optimism,’ ‘Beliefs 
about Consequences,’ ‘Reinforcement,’ ‘Intentions,’ ‘Goals,’ ‘Memory, Attention, and 
Decision Processes,’ ‘Environmental Context and Resources,’ ‘Social Influences,’ 
‘Emotion,’ and ‘Behavioral Regulation’.10  
Methods 
     This convergent parallel mixed methods study was conducted through the lens of the 
TDF. Quantitative data were collected using a Determinants of Implementation Behavior 
Questionnaire for Neonatal Abstinence Syndrome (DIBQ-NAS) that assessed nurses’ 
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perceptions of barriers and enablers to implementation of nonpharmacological 
interventions for infants with NAS. Qualitative semi-structured interviews and thematic 
analysis were conducted to describe nurses’ perceptions of barriers and enablers to 
implementation of nonpharmacologic nursing interventions. Merging of the interview and 
DIBQ-NAS results allowed for identification and prioritization of barriers and enablers. 
Data collection began after approval from the Institutional Review Board and the 
National Association of Neonatal Nurses (NANN) research committee. 
Qualitative Arm 
     A descriptive qualitative approach11 was applied to explore nurses’ perceptions of 
barriers and enablers to implementation of nonpharmacological interventions. Purposeful 
sampling was used to recruit participants from a Level II Neonatal Intensive Care Unit 
(NICU) at an academic medical center and by offering members of NANN who 
completed the DIBQ-NAS survey the option to participate in the interview. Participants 
who met the inclusion and exclusion criteria were enrolled in the study (Table 1).  
Table 1. Qualitative Inclusion and Exclusion Criteria  
Inclusion Criteria Exclusion Criteria 
Nurses must be licensed and registered to 
practice in their state 
Nurses whose primary NAS experience is 
related to infants withdrawing from 
opioids/sedatives because the infant is on 
mechanical ventilation. The type of NAS 
experience was evaluated by the PI during 
the participant screening process. 
For participants recruited from the Level II 
NICU, nurses must have at least 6 months’ 
experience caring for infants with NAS. 
 
     Semi-structured interviews were conducted using a guide with 8 open-ended 
questions, followed by a demographic survey. The interview explored nurses’ perceptions 
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and experiences with caring for infants with NAS; factors that impact the infants’ LOS; 
efficacy of withdrawal scoring instruments; and mothers’ responses and interactions with 
her infant. Interviews were conducted in person, in a private conference room, or via 
phone according to the participants’ preference, audio recorded, and transcribed. 
Theoretical saturation, the point at which no new information emerges in the data,12 was 
met with fifteen participants. 
     Interviews were analyzed using conventional content analysis13 to code data into 
common themes. The TDF was used as an initial coding framework, and the constant-
comparative method was applied throughout the process until theoretical saturation was 
met. 
     Demographic data were entered into REDCap14 and exported to SPSSv2515 for 
analyses. Descriptive statistics, including frequency distributions, measures of central 
tendency, and measures of dispersion or variation were computed on the demographic 
characteristics (gender, age, race/ethnicity, and level of education and nursing 
experience) of participants as appropriate. 
Quantitative Arm 
     A tailored DIBQ-NAS was administered to assess nurses’ perceptions of barriers and 
enablers to implementation of nonpharmacological interventions. Target sample size was 
367 participants based on a 95% confidence interval, a ±5% margin of error and an 
assumed standard deviation of 0.5.16 A link to the demographic survey and DIBQ-NAS, 
administered through REDCap14 via email, was sent to the membership of NANN 
(approximately 8200 members). A survey introduction and DIBQ-NAS link were posted 
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to MyNANN Community. Three additional reminders were posted every two weeks. The 
screening questionnaire reduced the study population to those meeting the inclusion 
criteria (Table 2). 
Table 2. Quantitative Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Nurses must be members of NANN, self-
report having at least 6 months’ 
experience caring for infants with NAS and 
have access to a computer with a valid 
email address. 
None 
     The DIBQ was developed to measure behavior determinants of the 12-domain version 
of the TDF.17 The initial DIBQ contained 100 items assessing the 12 TDF domains. 
Results obtained from confirmatory factor analysis and Cronbach’s alpha resulted in the 
DIBQ consisting of 93 items assessing an expanded 18 TDF domains, explaining 63.3% 
of the variance, and internal consistency reliability values ranged from .68 to .93. 
     The DIBQ was designed to be easily adaptable for use in studies investigating 
implementation behaviors of healthcare providers in various settings.18 Therefore, a 
tailored, more succinct version of the DIBQ was developed for this study, the DIBQ-
NAS (Appendix A). Tailoring was informed by findings from an integrative review5; the 
DIBQ-NAS consists of 11 items to assess nurses’ perceptions of Knowledge, Skills, 
Social/Professional Role and Identity, Beliefs about Capabilities, Environmental Context 
and Resources, Organization, and Emotion in caring for infants with NAS and their 
families. The DIBQ-NAS utilizes a Likert scale for responses, with lower values 
representing less confidence/agreement and higher values representing greater 
confidence/agreement. Data from the DIBQ-NAS and demographic surveys were stored 
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in REDCap14 and exported to SPSSv2515 for analyses. Descriptive statistics, including 
frequency distributions, measures of central tendency, and measures of variation were 
computed as appropriate. 
Merged Analysis 
     Results from the interviews and DIBQ-NAS were merged through joint display to 
compare and contrast findings according to TDF domains (Table 3). A frequency analysis 
was conducted by counting the number of interview participants who contributed to each 
theme to establish priority barriers and enablers. All themes in which 50% (n = 7) or 
more participants contributed data were considered priority. In addition, themes not 
meeting the frequency benchmark but considered highly relevant to the study purpose 
were also considered priority.  









     
Nurse Experience
    
Nurses' Implementation of Interventions
• " I think there needs to be more 
information for consistency of care all 
around. I think when you don't have 
primarily the same two, or three, or four 
nurses taking care of the patient, often the 
care can vary, and I think the way that we 
rate our NAS (infants) is still very subjective. 
I think there's still a lot of lack of education 
in how we rate it."
• “I think the longer you're taking care of 
the children, the easier it gets, and you can 
feel confident in caring for them and being 
able to calm them down."
• "I think the nurses are really important. 
They provide the soothing mechanisms to be 
able to hold the babies and score the babies. 
I feel like we're pretty competent. We're 
trained, we get that competency, so what 
we score them is going to impact whether 
their morphine is weaned or not, and then 
ultimately, their length of stay."
• I know how to deliver nonpharmacological 
interventions, 83.9% strongly agreed, 12.5% agreed, 
and 3.6% strongly disagreed.
• I have been trained in delivering 
nonpharmacological interventions, 57.1% strongly 
agreed, 32.1% agreed, 7.1% were neutral, and 3.6% 
strongly disagreed.
• The organization I work in provides nursing staff 
with training in implementing nonpharmacological 
interventions, 26.8% strongly agreed, 32.1% agreed, 
26.8% were neutral, 12.5% disagreed, and 1.8% 
strongly disagreed.
• For me, performing an accurate withdrawal 
assessment is..., 25% considered is very easy, 53.6% 
considered it easy, 10.7% were neutral, and 10.7% 
found it difficult.
• I have the skills to deliver nonpharmacological 
interventions, 75% strongly agreed, 21.4% agreed, 




    
Lack of Parental Participation
    
Stigmatization
• "The infants whose parents are committed 
and are there every day and staying for 
significant lengths of time, bonding with the 
baby, holding the baby; they typically have 
much lower scores and are able to wean 
faster and get discharged sooner."
• “I think because the parents can't be there 
24/7 because they usually have other kids at 
home so it's hard, your baby changes every 
day and it's hard for them to really get to 
know them, so I do feel like it's hard for 
them to bond.”
• “I can see that being a perception of the 
moms, and them not wanting to be in the 
nursery, because they're afraid of what 
people are thinking about them."
Not assessed
Organization Lack of Managerial/Organization Support
Staffing Ratios
Internal and External Resources
• "I would say the hospital approving more 
nurses to take care of these babies and 
understanding that sometimes they can be a 
one on one if they have to be, and 
supporting that, I would say that's currently 
not there. So as far as I'm concerned, there 
really isn't a lot of hospital support at this 
time."
• “I think patient ratio is probably the 
biggest challenge, finding enough time to 
work with the patient to give them the 
needed time to give the appropriate care.”
• “volunteers' ability to be there with the 
baby that's withdrawing, give them that 
comfort, I think would probably be the most 
valuable asset and resource that we can 
provide an NAS baby.”
• I can count on support from management of the 
organization I work in when it becomes challenging to 
care for infants with NAS, 33.9% strongly agreed, 
35.7% agreed, 17.9% were neutral, 10.7% disagreed, 
and 1.8% strongly disagreed.
• The management of the organization I work in is 
helpful with delivering care and implementing 
nonpharmacological interventions, 30.4% strongly 
agreed, 35.7% agreed, 25% were neutral, 7.1% 
disagreed, and 1.8% strongly disagreed.
• In the organization I work, all necessary resources 
are available to deliver nonpharmacological 
interventions, 35.7% strongly agreed, 33.9% agreed, 
14.3% were neutral, 14.3% disagreed, and 1.8% 
strongly disagreed.
• I can count on support from other nurses with whom 
I work when it becomes challenging to provide care, 
55.4% strongly agreed, 33.9% agreed, and 5.4% were 
neutral.
• The organization I work in provides assistance to 
nurses delivering care (for example, volunteers to 
hold infants), 30.4% strongly agreed, 48.2% agreed, 
7.1% were neutral, 12.5% disagreed, and 1.8% 
strongly disagreed.
Emotion Stress (S) • "You want to make them (infants with 
NAS) feel better. You want to care for them 
appropriately, but when you feel like you're 
exhausting all efforts to give them what they 
need, but it's not what they need, or it's not 
enough, and they're still just utterly 
miserable."
•"I think day in and day out, if it's a really 
difficult situation, it can definitely be 
stressful and fatiguing. Eventually at some 
point they're (nurses) going to need a 
break."
• "It wears you down sometimes to take 
care of these patients because you can't give 
them what they need, and so it is a little 
fatiguing to take care of them, especially if 
you have another patient or two that are 
taking up a lot of your time."
• The management of the organization I work in is 
willing to listen to my problems with delivering care 
to infants with NAS, 39.3% strongly agreed, 35.7% 





     Fifteen nurses (10 Level II NICU employees, 5 NANN members) participated in 
interviews (Table 4). Sixty-three nurses responded to the DIBQ-NAS; 5 did not provide 
responses beyond the screening questions and 2 did not meet the inclusion criteria. The 
final sample was 56 participants (Table 4).  
     Results of the frequency analysis led to five TDF domains meeting priority status: 
Knowledge, Skills, Beliefs about Capabilities, Social/Professional Role and Identity, and 
Emotion. The domain Organization did not meet the priority benchmark but was 
considered highly relevant and was included. 
Table 4. Interview and DIBQ-NAS Demographic Statistics 
 Interview Participants 
(n = 15) 
DIBQ-NAS Participants 
(n = 56) 
Gender (Female) 





Age in Years 
Mean ± SD (Median) 
 
37.1 ±12 (35) 
 
48.3 ±10.9 (51) 
Race/Ethnicity 
Asian 
Hispanic or Latino 
White 
Asian and White 
Hispanic or Latino and White 


























Years Working as a Nurse 
1-3 years 
4-6 years 
7 years or more 













Years Providing Care for Infants with NAS 
Less than one year 
1-3 years 
4-6 years 
7 years or more 













Frequency of Providing Care for Infants with NAS 
Less than once a week 
About once a week 
More than once a week 
Unknown 














General Service Level 1 Newborn Nursery 
General Service Level II Nursery 
Separate/Designated NAS unit 
Neonatal Intensive Care Unit (Level III or greater) 













Knowledge, Skills, and Beliefs about Capabilities 
     Most participants emphasized the importance of nurse education (n = 15), nurse 
experience (n = 12), and nurses’ implementation of nonpharmacological interventions (n 
= 10), which align with the TDF Knowledge, Skills, and Beliefs about Capabilities 
domains. 
     Nurse Education. According to participants, nurse education is crucial to nurse self-
efficacy, empathy, assessment skills, and knowledge of nonpharmacological and 
pharmacological interventions and the NAS diagnosis. Participants suggested that 
education may also mitigate potential biases towards mothers/families and their infants. 
Nurses' knowledge of the maternal, birth, and infant histories also highly impact nursing 
care. More education ensures consistency and assessment accuracy among care providers 
and across hospital units. In addition, participants suggested having educational materials 
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more readily available and accessible, such as imbedded educational scoring tools in 
charting software as an opportunity for real-time education to increase scoring accuracy. 
     According to DIBQ-NAS responses, over 90% of nurses believed they knew how to 
deliver nonpharmacological interventions for infants with NAS; however, only about half 
of nurses believed they received adequate training on implementing these interventions. 
The quantitative results further emphasize, as the interviewed participants suggested, the 
need for more education and training. 
     Nurse Experience. Participants posited that more experience caring for infants with 
NAS, specifically assessing and scoring the severity of withdrawal, leads to greater 
assessment accuracy and overall nurse self-efficacy. According to DIBQ-NAS responses, 
over 75% of nurses believed performing accurate withdrawal assessments to be easy. 
Over half of those interviewed and 75% of nurses who completed the DIBQ-NAS had 
more than 7 years of experience caring for infants with NAS. 
     Nurses’ Implementation of Nonpharmacological Interventions. Participants stated 
their ability to implement nonpharmacological interventions, including accurate and 
consistent withdrawal assessments and scoring of withdrawal symptoms, is crucial in 
determining pharmacological management, which can significantly alter the infant's LOS. 
In addition, managing withdrawal symptoms and ensuring the infant is feeding well and 
gaining weight are critical milestones in preparation for hospital discharge. 
     Nearly all nurses (96%) responded on the DIBQ-NAS that they believed they had the 
skills to deliver nonpharmacological interventions for infants with NAS. In addition to 
consistency of care, several participants (n = 9) discussed the importance of “continuity 
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of care” for the NAS parental-infant dyad. Participants indicated that the same nurse 
(when possible) caring for the infant was instrumental in reducing withdrawal symptoms 
and LOS and provided more accurate withdrawal assessments. According to participants, 
“continuity of care” naturally facilitates the nurse-parent relationship bond. Further, 
communication among nurses on an infant’s likes/dislikes of nonpharmacological 
interventions aids in the delivery of optimal care. 
Social/Professional Role and Identity 
     All participants discussed the importance of creating a welcoming environment to 
encourage parental participation (n = 15) in infant care by including them as an integral 
part of the care team. Several participants (n = 9) conveyed their concern regarding the 
lack of parental participation, and how parental uninvolvement creates barriers in the 
care. Numerous participants shared their views regarding how stigmatization (n = 8) and 
the perception of stigma (by parents) (n = 9) of infants with NAS and their families 
creates multiple barriers related to parental-infant and nurse-parent relationships. These 
themes align with the TDF ‘Social/Professional Role and Identity’ domain. 
     Parental Participation. According to participants, the nurses’ role is to create a 
welcoming environment and include parents as an integral part of the care team. A few 
participants (n = 4) posited that establishing roles, clear boundaries, and expectations can 
facilitate the development of the nurse-parent relationship. Nurse-guided parental 
education can improve both parental and infant outcomes. Participants noted that 
parental participation can positively influence self-efficacy, the parental-infant bond, and 
the relationship between the nurse and parent and may decrease parental guilt, and the 
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infant’s withdrawal scores and LOS. In addition, parental participation lends to greater 
understanding of the NAS condition and pharmacologic treatment. Further, nurses 
appreciate when parents attempt to understand and care for their infant to prepare for 
discharge home. This care includes providing soothing techniques similar to those 
utilized in the hospital, which can make the infant's transition more comfortable. 
     Conversely, participants (n = 10) discussed the lack of parental participation or 
understanding of the infant’s diagnosis and knowledge of appropriate 
nonpharmacological interventions as barriers to parental education, the development of 
the nurse-parent relationship, the parental-infant bond, and a source of nurse stress. 
Several participants (n = 6) described external factors such as maternal substance abuse 
treatment, distance from the hospital, having other children, and having jobs, which limit 
the time the parent can visit and care for their hospitalized infant and impairs their ability 
to bond effectively. In addition, separating the mother from her infant due to delivery 
complications, the initiation of pharmacologic treatment for the infant with NAS, 
visitation requirements of Children and Family Services, or other complex social issues 
also present barriers to parental participation and bonding.  
     Stigmatization. Several participants (n = 8) acknowledged stigmatization of parents 
such as, judgmental statements and rumors during shift report or excluding the parent in 
infant care, which creates barriers to the development of a positive nurse-parent 
relationship and adversely impacts the parent's desire to visit, self-efficacy, and bonding 
with the infant. Participants discussed how even the perception of stigma (n = 9) and 
internalized guilt felt by parents may negatively impact their desire to visit and self-
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efficacy. Most participants, regardless of their internal thoughts and beliefs about this 
opioid-exposed patient population, remain professional, provide the best care, and desire 
to teach parents infant care.  
Organization 
     All participants (n = 15) addressed concerns regarding the amount of “hands-on” time 
infants with NAS require and the lack of managerial/organizational support (n = 6) as 
evidenced by inadequate staffing ratios (n = 15). Due to inadequate staffing ratios, 
participants expressed gratitude for and dependence on volunteers (external team 
resource; n = 15), and fellow internal staff members and interdisciplinary team members 
(internal team resource; n = 12) to fully support care standards for infants with NAS and 
their families. These themes align with the ‘Organization’ domain of the TDF. 
     Lack of Managerial/Organizational Support. Several participants (n = 6) reported 
management exhibiting a lack of understanding and knowledge of NAS and the time 
required to care for patients and their families, which led management to question unit 
staffing ratios. Participants posited that managerial support is needed to ensure 
appropriate staffing ratios are maintained. Some participants also suggested more 
managerial presence and support are needed during night/weekend shifts. However, 
quantitative findings indicated most participants felt supported by management. DIBQ-
NAS responses indicated nearly 70% of nurses believed they could count on support 
from management when it became challenging to care for infants with NAS. Similarly, 
more than 65% of nurses believed management was helpful with delivering care and 
implementing nonpharmacological interventions. 
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     Staffing Ratios. Participants stated infants with NAS require more time to care for 
than the average patient, which should be reflected in staffing ratios. Inadequate staffing 
ratios limit time with the infant, increase nurse stress, and lead to more errors and 
inaccurate withdrawal scores. However, DIBQ-NAS responses indicated nearly 70% of 
nurses believed their organization had all necessary resources available to deliver 
nonpharmacological interventions. These findings contradict the results from the 
interviews, which indicated nurses felt “under-staffed” and without enough time to care 
for infants with NAS properly. 
     Internal and External Resources. All participants emphasized the importance of 
volunteers when caring for infants with NAS and their families. They believed that more 
volunteers are needed, particularly during night and weekend shifts. Participants stated 
that volunteers are invaluable resources who hold and comfort infants, which reduces 
withdrawal symptoms and allows nurses to care for other patients. Further, most 
participants (n = 12) conveyed the importance of “teamwork” and stated that 
interdisciplinary team support (occupational therapy, physical therapy) can reduce the 
infant’s LOS, and improve care and overall infant outcomes. Participants added that 
incorporating a “family integrated model of care” allows parents to provide care without 
depending on the nurse, which promotes flexibility in staffing ratios.  
     The findings from the DIBQ-NAS were consistent with interview results. Responses 
on the DIBQ-NAS indicated nearly 90% of nurses believed they could count on support 
from other nurses when it became challenging to provide care for infants with NAS. 
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Further, over 75% of nurses believed their organization assists nurses delivering care to 
infants with NAS. 
Emotion 
     Nurse stress was one of the most common themes (n = 15). The sources of stress vary 
widely, which creates challenges to providing proper support for nurses. The TDF 
domain most closely aligned with stress is ‘Emotion’. 
     Stress. Several participants (n = 7) said they experience heartbreak and frustration 
when thinking about the infant’s diagnosis, its impact on the infant's life, and the infant's 
life once discharged from the hospital, all while trying to deliver the best care. The 
infant’s uncertain plan for the future (which may include going home with a foster parent, 
relative, etc.) impacts the nurses’ bond with the infant and leads to stress. The complex 
social issues often exhibited in families and the amount of education nurses provide to the 
family also increase nurse stress. Additionally, it can be frustrating and stressful for the 
nurse who is unable to soothe and comfort an infant experiencing withdrawal. 
Participants indicated caring for infants with NAS, particularly during consecutive shifts, 
contributes to nurse stress and fatigue. Participants emphasized the importance of 
knowing their limitations, relying on resources, and taking breaks. 
     According to DIBQ-NAS responses, 75% of nurses believed that management was 
willing to listen to their problems with delivering care to infants with NAS. The merged 
findings suggest that although nurses experience stress caring for infants with NAS and 





     The purpose of this study was to investigate barriers and enablers to nurses’ 
implementation of nonpharmacological interventions for infants with NAS through the 
lens of the TDF. Knowledge, Skills, and Social/Professional Role and Identity are the 
most influential TDF domains for providers’ implementation of nonpharmacological 
interventions aimed at decreasing the LOS for infants with NAS.5 Other potentially 
influential contextual and environmental TDF domains such as, Beliefs about 
Capabilities, Environmental Context and Resources, Organization, and Emotion were 
also explored in this study. 
     Knowledge was identified as a key influential TDF domain. Specific and ongoing 
education related to the NAS continuum of care, from early detection and intervention for 
mothers and infants at risk through post-discharge identification and utilization of 
community support services, is crucial to improving overall outcomes.19 Further, greater 
knowledge of the NAS diagnosis, treatment modalities, infant comfort measures, and 
withdrawal assessment criteria enhances nurse self-efficacy,20-22 mitigates stigmatization 
of the NAS parental-infant dyad,23 and enables nurses to effectively implement 
nonpharmacological interventions. 
     Once a solid foundation of knowledge has been established, nurses can refine their 
skill set by gaining more experience in implementing nonpharamcolgoical interventions. 
Skill, another highly influential TDF domain, is established through caring for infants 
with NAS more frequently, incorporating unit “NAS core teams” (a team of nurses 
committed to caring for these infants every shift), and when possible, providing 
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“continuity of care.” The synergistic combination of greater knowledge and refined skill 
results in more accurate withdrawal assessments and consistency in care, which has been 
shown to decrease infant withdrawal severity and LOS.24 
     Consistency of care was identified as a key enabler to the effective implementation of 
nonpharmacological interventions. The utilization of a withdrawal protocol is an 
evidence-based, recommended strategy to establish a consistent, standard of care for 
infants with NAS.24-27 Important caveats to this strategy include incorporating nurses’ 
input in the infants’ plans of care and recognizing patient individuality. Nurses, due to the 
considerable amount of time spent caring for the NAS parental-infant dyad, are well 
positioned to advise the care team and advocate for their patients and families to ensure 
the best overall outcomes. 
     Nurses are a crucial component in the delivery of care for infants with NAS; however, 
most nurses believe that parental participation in care is far more significant, particularly 
as it relates to parental self-efficacy, parental-infant bonding, and the reduction of infant 
withdrawal severity and LOS.28 Therefore, by nurses embracing their unique role and 
creating a welcoming environment that includes parents as an integral part of the care 
team, a family integrated model of care can be established. This care model has been 
successful in enhancing the parental-infant bond, limiting treatment with medications, 
and reducing infant withdrawal severity and LOS.28 
     The successful implementation of a family integrated model of care requires unbiased 
support from interdisciplinary care team members. Although stigmatization of patient 
populations is of considerable concern to healthcare providers, it is representative of the 
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more significant issue of societal marginalization of those with Opioid Use Disorder 
(OUD). Stigmatization of those with OUD by healthcare providers is a significant barrier 
to effective and optimal treatment for pregnant women.29 Further, when women with 
OUD do access healthcare, they often receive misinformation, inaction, and judgmental 
attitudes by healthcare providers.30 Findings from this study indicate stigmatization 
results in barriers to parental participation in infant care, self-efficacy, development of the 
nurse-parent relationship, and parental-infant bonding. Therefore, due to the significant 
increase in patients with OUD, healthcare organizations should invest in training and 
education programs to support providers’ delivery of unbiased healthcare to vulnerable 
patient populations. 
     Organization was identified as an influential TDF domain, and organizational support 
was a key enabler to nurses’ implementation of nonpharmacological interventions. While 
most patient caregiving responsibilities fall to nurses, healthcare organizations are 
obligated to ensure care team members are equipped with the necessary resources to 
deliver optimal care to patients. Organizational support not only includes investing in 
training and education for providers, but also maintaining adequate staffing ratios to 
ensure more challenging patients receive optimal care. Further, the inclusion and training 
of volunteers and nursing assistants in comforting infants with NAS was viewed as an 
extremely valuable resource in this study. Healthcare organizations can support nursing 
staff by acknowledging and understanding the complexities of NAS care, offering a 
multidisciplinary caregiving team approach,24,28 and investing in all necessary resources 
to assist those who deliver care. 
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     One of the more insidious barriers to nurses’ implementation of nonpharamcolgoical 
interventions was stress. Sources of participants’ stress varied widely, which complicates 
organizational efforts to mitigate nurse fatigue and its far-reaching effects.31 These 
findings are congruent with other studies that found nurses providing NAS care 
experienced intensified traumatic experiences,32 ethical and moral distress,33 and were at 
risk for compassion fatigue and burnout.34 Smith-Miller and colleagues35 posited that 
addressing job-related factors could reduce nurse fatigue, errors, attrition and employer 
costs while improving patient outcomes and job satisfaction among nurses. However, 
addressing and monitoring fatigue in healthcare organizations remains challenging due to 
lack of evidence-based fatigue policies.31 Despite the lack of evidence-based fatigue 
policies, healthcare organizations should create a culture of safety by collaborating with 
nurse leaders to develop strategies to manage nurse fatigue.31 
Limitations 
     The development of the DIBQ-NAS was informed by findings of an integrative 
review5, in which the TDF domains Knowledge, Skills, and Social/Professional Role and 
Identity were identified as having the greatest influence on providers’ implementation of 
nonpharmacological interventions to decrease the LOS for infants with NAS. Results 
from the qualitative analysis identified other areas related in the Social/Professional Role 
and Identity domain, such as parental participation, lack of parental participation, and 
stigmatization that should be included in an expanded version of the DIBQ-NAS. Despite 
attempts to recruit the targeted 367 participants, only 56 nurses completed the DIBQ-
NAS. The small sample limited the ability to conduct linear modeling and predictive 
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statistical analyses. Also, volunteer sampling approaches were used in this exploratory 
study, which could limit the generalizability of the findings. 
Implications for Practice 
     Nurses consistently rate higher in honesty and ethics than all other professions,36 
comprise the majority of healthcare providers,37 deliver the most frequent, direct care to 
patients, and are poised to transform the model and delivery of care for infants with NAS 
and their families. Nurses have a unique role in delivering care to vulnerable and 
marginalized patient populations, such as the NAS parental-infant dyad, and therefore 
require training and educational programs on OUD and associated sequelae. Findings 
from this study will inform the development of programs to improve nurses’ 
implementation of nonpharmacological interventions and health and utilization outcomes 
in infants with NAS. 
Implications for Research  
     Future research should focus on the development of programs to improve nurses’ 
implementation of nonpharmacological interventions for infants with NAS, with specific 
strategies aimed to mitigate marginalization of vulnerable patient populations. Further, 
the DIBQ-NAS should be expanded to include questions related to key themes identified 
through qualitative analysis such as parental participation, lack of parental participation, 
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Appendix A: DIBQ-NAS 
Adapted from the DIBQ Final questionnaire 
 
For the purpose of completing this survey, the definition of “nonpharmacological 
intervention(s)” includes the following nursing activities:  
 
• Withdrawal assessment of the infant with Neonatal Abstinence Syndrome (NAS) 
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding 
support when indicated, non-nutritive sucking, inclusion of the mother in the care of her 
infant 
• Utilization of a withdrawal scoring instrument 
 
1. I know how to deliver nonpharmacological interventions for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
2. I have been trained in delivering nonpharmacological interventions for infants with 
NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
3. I have the skills to deliver nonpharmacological interventions for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
4. In the organization I work, all necessary resources are available to deliver 
nonpharmacological interventions to infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
5. I can count on support from management of the organization I work in, when it 
becomes challenging to provide care for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
6. The management of the organization I work in is willing to listen to my problems with 
delivering care to infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
7. The management of the organization I work in is helpful with delivering care and 
implementing nonpharmacological interventions for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
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Appendix A: DIBQ-NAS (continued) 
 
8. The organization I work in provides nursing staff with training in implementing 
nonpharmacological interventions for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
9. For me, performing an accurate withdrawal assessment for infants with NAS is… 
______Very difficult ________Difficult  _______Easy     _______Very easy 
 
10. The organization I work in provides assistance to nurses in delivering care to infants 
with NAS. (for example, volunteers who hold infants). 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
11. I can count on support from other nurses with whom I work when it becomes 
challenging to provide care for infants with NAS. 
______Strongly Disagree    _______Disagree    _______Agree    _______Strongly Agree 
 
If you are interested in participating in a telephone interview regarding nurses’ 
perceptions of barriers and enablers to implementation of nonpharmacological nursing 
interventions for infants with NAS, please indicate your interest by checking next to the 
‘Yes’ statement below. 
















DIBQ-NAS NANN Survey Descriptive Statistics (n = 56)
Strongly Agree Agree Neutral Disagree Strongly Disagree
I know how to deliver nonpharmacological 
interventions for infants with NAS.
83.9% (47) 12.5% (7) 0% (0) 0% (0) 3.6% (2)
I have been trained in delivering 
nonpharmacological interventions for infants 
with NAS.
57.1% (32) 32.1% (18) 7.1% (4) 0% (0) 3.6% (2)
I have the skills to deliver 
nonpharmacological interventions for infants 
with NAS.
75% (42) 21.4% (12) 0% (0) 0% (0) 3.6% (2)
In the organization I work, all necessary 
resources are available to deliver 
nonpharmacological interventions to infants 
with NAS.
35.7% (20) 33.9% (19) 14.3% (8) 14.3% (8) 1.8% (1)
I can count on support from management of 
the organization I work in, when it becomes 
challenging to provide care for infants with 
NAS.
33.9% (19) 35.7% (20) 17.9% (10) 10.7 (6) 1.8% (1)
The Management of the organization I work 
in is willing to listen to my problems with 
delivering care for infants with NAS.
39.3% (22) 35.7% (20) 17.9% (10) 5.4% (3) 1.8% (1)
The management of the organization I work 
in is helpful with delivering care and 
implementing nonpharmacological 
interventions for infants with NAS.
30.4% (17) 35.7% (20) 25% (14) 7.1% (4) 1.8% (1)
The organization I work in provides nursing 
staff with training in implementing 
nonpharmacological interventions for infants 
with NAS.
26.8% (15) 32.1% (18) 26.8% (15) 12.5% (7) 1.8% (1)
I can count on support from other nurses 
with whom I work when it becomes 
challenging to provide care for infants with 
NAS.
55.4% (31) 39.3% (22) 5.4% (3) 0% (0) 0% (0)
The organization I work in provides 
assistance to nurses delivering care to infants 
with NAS. (for example, volunteers to hold 
infants)
30.4% (17) 48.2% (27) 7.1% (4) 12.5% (7) 1.8% (1)
Very Easy Easy Neutral Difficult Very Difficult
For me, performing an accurate withdrawal 
assessment for infants with NAS is…
25% (14) 53.6% (30) 10.7% (6) 10.7% (6) 0% (0)
For the purpose of completing the survey, the definition of "nonpharmacological intervention(s)" included the following nursing activities:
• Withdrawal assessment of the infant with NAS
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding support when indicated, non-nutritive sucking,
   and the inclusion of the mother/parent in the care of the infant
• Utilization of a withdrawal scoring instrument
Abbreviation: NAS, Neonatal Abstinence Syndrome




Table 1: Qualitative Inclusion and Exclusion Criteria 
Table 2: Quantitative Inclusion and Exclusion Criteria 
Table 3: Qualitative and Quantitative Joint Display 
Table 4: Interview and DIBQ-NAS Demographic Statistics 





















This dissertation study is comprised of three manuscripts, each contributing to the 
identification and examination of key barriers and enablers to healthcare providers’ 
implementation of nonpharmacological interventions in the care of infants with Neonatal 
Abstinence Syndrome (NAS) and their families. The first manuscript is a scoping review 
of the literature on the benefits of breastmilk for the methadone dependent maternal-
infant dyad. The second manuscript is an integrative review which identified the factors 
that influence healthcare providers’ behaviors in the care of infants with NAS. The third 
and final manuscript explores barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with NAS.  
The scoping review, guided by the Social Ecological Model (SEM), served as the 
foundation for the dissertation study. Research has shown that despite the American 
Academy of Pediatrics’ recommendation for mothers in methadone treatment to 
breastfeed, breastfeeding is initiated at significantly lower rates than in the general 
population (1). Understanding this discrepancy and the factors associated with infant 
feeding decisions is important because breastfeeding has been shown to be a key 
nonpharmacologic intervention that decreases infant withdrawal severity and length of 
stay (LOS) (2-8), while improving infant nutrition, and promoting maternal self-efficacy 
and maternal-infant bonding (6, 9-11). The scoping review findings suggested that many 
barriers prevent mothers in methadone treatment from breastfeeding, including: 
inconsistent advice from healthcare providers; lack of clear guidelines; feeding problems 
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(associated with NAS sequalae); lengthy hospital stays that prohibit maternal-infant 
bonding; and issues such as low self-esteem, lack of knowledge, or feelings of maternal 
guilt (6, 12, 13). Health care providers should be knowledgeable about current 
breastfeeding guidelines for mothers in methadone treatment so they are better equipped 
to offer nonjudgmental, supportive counsel regarding common breastfeeding challenges 
and maternal concerns (14). 
The integrative review, guided by the Whittemore and Knafl methodology (15), 
was the keystone for this dissertation study. The keystone is a central component on 
which all else depends. The Theoretical Domains Framework (TDF) served as the lens 
through which the current knowledge of individual and contextual factors that influence 
healthcare providers’ behaviors in implementing nonpharmacological interventions was 
examined. The integrative review findings were critical to this dissertation study because 
the most influential TDF domains relevant to implementation of nonpharmacological 
interventions aimed at decreasing the LOS for infants with NAS were identified, which 
included Knowledge, Skills, and Social/Professional Role and Identity. 
The primary themes within the TDF domains included: knowledge of NAS and 
American Academy of Pediatrics recommendations on NAS management, nursing 
competence (assessment skills and effective utilization of a withdrawal scoring 
instrument), development of interpersonal relationships with parents within professional 
boundaries, establishment of role within a multidisciplinary team, and leadership in the 
management and care of infants with NAS. In addition to the Knowledge, Skills, and 
Social/Professional Role and Identity domains, other potentially influential contextual 
86 
 
and environmental TDF domains such as, Beliefs about Capabilities, Environmental 
Context and Resources, Organization, and Emotion were incorporated into the 
dissertation study to ensure the inclusion of all potential barriers and enablers to nurses’ 
implementation of nonpharmacological nursing interventions.  
The final manuscript presents findings from a convergent parallel mixed methods 
study, conducted through the lens of the TDF, which identifies and prioritizes barriers 
and enablers to nurses’ implementation of nonpharmacological interventions for infants 
with NAS. Joint review of qualitative and quantitative data was conducted, and the most 
influential enablers and barriers were as follows: nurse education, nurse experience, 
nurses’ ability to implement nonpharmacological interventions, parental participation, 
stigmatization, lack of managerial/organizational support, staffing ratios, internal and 
external resources, and stress. The TDF domains Knowledge, Skills, Beliefs about 
Capabilities, Social/Professional Role and Identity, Organization, and Emotion aligned 
with these themes. 
Importance of Theoretical Framework 
The TDF, a theoretical framework comprised of behavior change theories, 
provides a structure to examine factors that influence healthcare providers’ behavior 
related to the implementation of evidence-based practice and interventions in clinical 
practice (16). The TDF was instrumental in this dissertation work because it provided the 
lens through which influential factors in healthcare providers’ behaviors were identified 
during the integrative review and served as the initial coding framework to identify 
specific themes in the dissertation study. The TDF was selected as the guiding theoretical 
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framework for this dissertation study because the TDF was developed as a 
multidisciplinary tool to aid in the identification of influential behavioral factors to 
develop effective strategies when implementing evidence-based interventions. 
Limitations and Lessons Learned 
The development of the tailored survey instrument for the dissertation study, the 
Determinants of Implementation Behavior Questionnaire for Neonatal Abstinence 
Syndrome (DIBQ-NAS), was informed by findings of the integrative review, in which 
the TDF domains Knowledge, Skills, and Social/Professional Role and Identity had the 
greatest influence on providers’ implementation of nonpharmacological interventions. 
However, results from the qualitative analysis indicated other themes in the 
Social/Professional Role and Identity domain, such as parental participation, lack of 
parental participation, and stigmatization should be included in an expanded version of 
the DIBQ-NAS.  
Further, application of the TDF in the integrative review was challenging because 
not all domains are mutually exclusive. To mitigate this challenge in the dissertation 
study, data from participant interviews were analyzed using conventional content analysis 
(17) to code data into themes. The TDF was the initial coding framework and the 
constant-comparative method of data analysis was used throughout the process until 
theoretical saturation was met.  
In addition, despite attempts to recruit the goal of 367 participants for the DIBQ-
NAS, such as sending reminders and offering gift card drawings, only 56 nurses 
completed the survey. The small sample size limited the ability to conduct linear 
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modeling and predictive statistical analyses. Volunteer sampling was used in this 
dissertation study, which may limit the generalizability of findings. 
Research Trajectory 
In response to recollection of a meaningful verse, “the dissertation is not my last 
word, rather it’s my first word,” the immediate next step in this research trajectory will be 
to craft and submit two additional manuscripts presenting the findings from this 
dissertation study.  
More distal next steps in the trajectory will include expansion of the DIBQ-NAS 
to include questions related to key themes identified through qualitative analysis such as 
parental participation, lack of parental participation, and stigmatization, which aligned 
with the Social/Professional Role and Identity TDF domain. While these themes were 
considered high priority according to the qualitative frequency analysis, there were no 
correlating survey questions that addressed these key themes. In addition, the findings 
from this study will inform the development of programs to improve nurses’ 
implementation of nonpharmacological interventions in the care of infants with NAS, 
with specific strategies aimed to mitigate marginalization of vulnerable patient 
populations. 
Contribution to Nursing and Clinical Care 
 Although significant research has been dedicated to pharmacologic treatment for 
infants with NAS, there are very few studies that provide empirical evidence to guide 
specific nonpharmacological interventions aimed to decrease the LOS for infants with 
NAS. Further, until this dissertation study, there were no studies that incorporated the 
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TDF as a structure to guide the development of strategies that influence healthcare 
providers’ behavior related to the implementation of evidence-based practice and 
interventions in clinical practice. 
Through a scoping review, the benefits of breastmilk for the opioid-dependent 
maternal-infant dyad were identified, factors associated with  breastfeeding initiation for 
the opioid-dependent maternal-infant dyad as they correlated to the SEM were evaluated, 
and the importance of treating the infant with NAS as part of the maternal-infant dyad 
was established. Further, health outcomes for the NAS maternal-infant dyad can be 
improved through interventions that create a more welcoming, nonjudgmental, and 
comfortable environment. 
Factors that influence healthcare providers’ behaviors in implementing 
nonpharmacological interventions to decrease the LOS for infants with NAS were 
identified through an integrative review. Key factors included implementing evidence-
based protocols, providing specialized training programs for healthcare providers, 
including parents as an integral part of the care team; utilizing validated withdrawal 
scoring instruments; and incorporating interdisciplinary team members in the care of 
infants with NAS to improve outcomes.  
Finally, results from the dissertation study can be applied to develop programs to 
improve nurses’ implementation of nonpharmacological interventions in the care of 
infants with NAS and their families. The most influential enablers and barriers to nurses’ 
implementation of nonpharmacological interventions were education, experience, ability 
to implement nonpharmacological interventions, parental participation, stigmatization, 
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lack of managerial/organizational support, staffing ratios, internal and external resources, 
and stress. These qualitative themes correlate to the TDF domains Knowledge, Skills, 
Beliefs about Capabilities, Social/Professional Role and Identity, Organization, and 
Emotion. Findings indicate key areas that programs should target to improve nurses’ 
implementation of nonpharmacological nursing interventions in the care of infants with 
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9. What is the care setting in which you provide care for infants with Neonatal Abstinence 
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     Hello, Thank you for meeting with me today and consenting to discuss your professional 
insight regarding the care provided for infants diagnosed with Neonatal Abstinence Syndrome 
(NAS). 
My name is Allison Adrian, and I am a doctoral student in the nursing research program at the 
College of Nursing at the Medical University of South Carolina. This interview, a component of a 




     Your privacy and anonymity is of utmost importance; therefore, your identity will be kept 
confidential. Discussing sensitive subject matter, such as the care of infants with NAS, can be 
emotionally troubling; if at any point during the interview you feel unable to continue, please feel 
free to stop the interview. We can continue and/or reschedule the interview at your 
convenience. The interview will be audio recorded for transcription purposes and will last 
approximately 45 minutes. The audio recording will be destroyed immediately after the 
information has been transcribed and analyzed. The information gained from this interview will 





1. Please describe your experience as a nurse caring for infants diagnosed with Neonatal 
Abstinence Syndrome (NAS). 
   
  Prompts 
  a. What challenges/frustrations do you experience when providing care for infants with 
 NAS? 
  b. What resources/support do you have available when providing care for infants with 
 NAS? 
  c. What resources do you feel are needed when providing care for infants with NAS? 
 
2. What factors do you believe impact the length of stay for infants with NAS? 
 
  a. What impact do you believe nursing care has on the length of stay for infants with 
 NAS?  
  b. What impact do you believe the NAS pharmacological protocol has on the length of 
 stay for infants with NAS? 
  c. What impact do you believe the neonatologists’ methodology has on the length of stay 
 for infants with NAS? 
  d. What impact do you believe parents have on the length of stay for infants with NAS? 
  e. What do you think would help reduce the length of stay for infants with NAS? 
 
3. What are your perceptions regarding the modified Finnegan scoring tool (F-NAST) in 
the care of infants with NAS? 
   
  Prompts 
  a. What education did you receive during orientation/training regarding the assessment 
 of infants with NAS and the utilization of the modified Finnegan scoring tool? How would 
 you modify, if at all, the education and/or how it is currently implemented? 
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 Appendix 2 – Interview Guide for Neonatal Nurses (continued) 
 
 c. How important do you believe education is in developing a nurses’ confidence in their ability 
 to accurately assess and score an infant with NAS? 
 
4. Please describe the hospital’s role in supporting nursing care of infants with NAS? 
   
Thank you very much for your responses to my questions so far – I would like to change 
topics and discuss your thoughts regarding the relationship between the nurse and the 
mother of the infant with NAS. 
  
5. Please share your thoughts on the role the care provider-mother relationship plays in 
the infant’s progress. 
  
  a. Do you feel that stigma exists between nurses and mothers of infants with NAS? 
  b. Have you ever witnessed a mother being stigmatized by a nurse? If so, please share 
 your experience. 
     
6. Do you think the mother’s perception of stigma (whether it exists or not) has an impact 
on the maternal-infant bond? (i.e., Do you feel it impacts the mother’s visiting time, care she 
provides her infant, her self-confidence in caring for her infant?) 
 
7. Generally speaking, what are your perceptions regarding the mother’s responses and 
interactions with her infant with NAS? 
   
  a. Based upon your experience, do you feel mothers are able to bond with their infants? 
 Please discuss your perceptions of facilitators and/or barriers to the mother-infant 
 bonding process. 
       
8. How important do you believe the following factors are in caring for infants with NAS; 
a nurse’s personality, nursing experience, knowledge of condition, knowledge of 
nursing interventions? 
   
  a. Were you taught (nonpharmacological) nursing interventions to calm and soothe 
 infants with NAS? 
  b. Do you think nurses experience more fatigue and distress when caring for infants with 
 NAS? 




      I greatly appreciate you sharing your perspective regarding this vulnerable mother-infant 
dyad. Please share any other thoughts or suggestions you may have with regard to caring for 
these infants or the questions that have been asked during this interview. If necessary, would it 
be acceptable for me to contact you for clarifications during the transcription and analytical 
phase of data collection? I will provide you with a brief summary of the findings and major 
themes identified once data collection and data analysis has been completed. Thank you again 
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Appendix 3 – DIBQ-NAS 
 
Adapted from the DIBQ Final questionnaire 
 
For the purpose of completing this survey, the definition of “nonpharmacological 
intervention(s)” includes the following nursing activities:  
 
• Withdrawal assessment of the infant with Neonatal Abstinence Syndrome (NAS) 
• Provision of caregiving interventions; for example, swaddling, holding, breastfeeding support 
when indicated, non-nutritive sucking, inclusion of the mother in the care of her infant 
• Utilization of a withdrawal scoring instrument 
 
1. I know how to deliver nonpharmacological nursing interventions for infants with NAS. 
(Domain: Knowledge; Construct: Knowledge) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
2. I have been trained in delivering nonpharmacological nursing interventions for infants with 
NAS. 
(Domain: Skills; Construct: Skills) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
3. I have the skills to deliver nonpharmacological nursing interventions for infants with NAS. 
(Domain: Skills; Construct: Skills) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
4. In the organization I work, all necessary resources are available to deliver 
nonpharmacological interventions to infants with NAS. 
(Domain: Organization; Construct: Organizational resources and support) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
5. I can count on support from management of the organization I work in, when it becomes 
challenging to provide care for infants with NAS. 
(Domain: Organization; Construct: Organizational resources and support) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
6. The management of the organization I work in is willing to listen to my problems with 
delivering care to infants with NAS. 
(Domain: Organization; Construct: Organizational resources and support) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
7. The management of the organization I work in is helpful with delivering care and 
implementing nonpharmacological interventions for infants with NAS. 
(Domain: Organization; Construct: Organizational resources and support) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
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Appendix 3 – DIBQ-NAS (continued) 
 
8. The organization I work in provides nursing staff with training in implementing 
nonpharmacological interventions for infants with NAS. 
(Domain: Innovation strategy; Construct: Innovation strategies) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
9. For me, performing an accurate withdrawal assessment for infants with NAS is… 
(Domain: Beliefs about capabilities; Construct: Perceive behavioral control) 
________Very difficult _________Difficult  ________Easy     ________Very easy 
 
10. The organization I work in provides assistance to nurses in delivering care to infants with 
NAS. (for example, volunteers who hold infants). 
(Domain: Innovation strategy; Construct: Innovation strategies) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
11. I can count on support from other nurses with whom I work when it becomes challenging to 
provide care for infants with NAS. 
(Domain: Social Influences; Construct: Social support) 
________Strongly Disagree    ________Disagree    ________Agree    ________Strongly Agree 
 
If you are interested in participating in a telephone interview regarding nurses’ perceptions of 
barriers and enablers to implementation of nonpharmacological nursing interventions for infants 
with NAS, please indicate your interest by checking next to the ‘Yes’ statement below. 
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Appendix 4 - Information for Interview Participants document 
 
 
Barriers and Enablers to Nurses’ Implementation of Nonpharmacological 
Interventions for Infants with Neonatal Abstinence Syndrome (NAS). 
 
You are being asked to participate in a research study. A study to investigate barriers 
and enablers to nurses’ implementation of nonpharmacological interventions for infants with 
Neonatal Abstinence Syndrome (NAS) will be conducted to inform the development of 
educational programs for nurses aimed at facilitating the implementation of nonpharmacological 
nursing interventions to improve the care of a vulnerable and rapidly-growing patient population: 
the NAS maternal-infant dyad. 
We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS) 
and have at least 6 months of experience caring for infants diagnosed with NAS. Study 
participants will be nurses recruited from the Level 2 Neonatal Nursery at the Medical University 
of South Carolina (MUSC) and the National Association of Neonatal Nurses (NANN).  
Study participants will be asked to complete a demographic survey and interview with 
the principal investigator, which should take approximately 45 minutes. The interviews will be 
conducted in a private conference room at the Children’s Hospital at MUSC, or via phone or 
videoconference according to the participants’ preference. Study participants recruited from 
NANN will be asked to complete a demographic survey administered through REDCap via 
email. 
Your confidential participation in this study is voluntary. Participants will receive no direct 
benefit from the study. However, the information gained from this study will inform the 
development of educational programs for nurses to improve the care of the NAS maternal-infant 
dyad. If you are interested in being a part of this study, or if you would like more information, 
please call or email Allison at (843) 819-8946 or adrian@musc.edu. 
 
Thank you, 
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  1 of 1 
Appendix 5 - Information for Survey Participants document 
 
 
Barriers and Enablers to Nurses’ Implementation of Nonpharmacological 
Interventions for Infants with Neonatal Abstinence Syndrome (NAS). 
 
You are being asked to participate in a research study. A study to investigate barriers 
and enablers to nurses’ implementation of nonpharmacological interventions for infants with 
Neonatal Abstinence Syndrome (NAS) will be conducted to inform the development of 
educational programs for nurses aimed at facilitating the implementation of nonpharmacological 
nursing interventions to improve the care of a vulnerable and rapidly-growing patient population: 
the NAS maternal-infant dyad. 
We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS) 
and have at least 6 months of experience caring for infants diagnosed with NAS. Study 
participants will be recruited from the National Association of Neonatal Nurses (NANN) utilizing 
the NANN Listservs resource. Study participants will be asked to complete a demographic 
survey and a tailored Determinants of Implementation Behavior Questionnaire (DIBQ-NAS), 
administered via REDCap through email, which should take approximately 10 minutes. 
Your confidential participation in this study is voluntary. Participants will receive no direct 
benefit from the study. However, the information gained from this study will inform the 
development of educational programs for nurses to improve the care of the NAS maternal-infant 
dyad. If you are interested in being a part of this study, or if you would like more information, 
please call or email Allison at (843) 819-8946 or adrian@musc.edu. 
 
Thank you, 
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Barriers and Enablers to Nurses’ Implementation of Nonpharmacological 
Interventions for Infants with Neonatal Abstinence Syndrome (NAS). 
 
You are being asked to participate in a research study. 
 
A study to investigate barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with Neonatal Abstinence Syndrome (NAS) will 
be conducted to inform the development of educational programs for nurses aimed at 
facilitating the implementation of nonpharmacological nursing interventions to improve the 





●    We will be recruiting nurses who are familiar with Neonatal Abstinence Syndrome (NAS) and 
have at least 6 months of experience caring for infants diagnosed with NAS. Study participants will 
be nurses recruited from the Level 2 Neonatal Nursery at the Medical University of South Carolina 
(MUSC) and the National Association of Neonatal Nurses (NANN).  
 
●    Study participants will be asked to complete a demographic survey and interview with the 
principal investigator, which should take approximately 45 minutes. The interviews will be conducted 
in a private conference room at the Children’s Hospital at MUSC, or via phone or videoconference 
according to the participants’ preference. Study participants recruited from NANN will be asked to 
complete a demographic survey administered through REDCap via email. 
 
●    Your confidential participation in this study is voluntary. Participants will receive no direct benefit 
from the study. However, the information gained from this study will inform the development of 
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A. SPECIFIC AIMS 
 
Specific Aims 
     Among neonates with in-utero exposure to opioids, an estimated 60-90% experience drug 
withdrawal, a condition defined as Neonatal Abstinence Syndrome (NAS) (1). In the United States, the 
incidence of NAS increased 383% from 2000 to 2012 (2). In 2012, infants with NAS stayed in the 
hospital an average of 16.9 days (compared to 2.1 days for healthy newborns), costing hospitals an 
estimated $1.5 billion; the majority of these charges (81%) were paid by state Medicaid programs, 
reflecting the greater tendency of opiate-abusing mothers to be from lower income communities (3). 
NAS often results in prolonged hospitalization and extensive pharmacological therapy and is 
characterized by a wide array of deleterious symptoms and complications, including increased 
irritability, hypertonia, tremors, feeding intolerance, emesis, watery stools, seizures, and respiratory 
distress (4). Extensive research has been conducted on pharmacologic treatment for infants with NAS. 
Specifically, researchers agree that opiates (oral morphine, methadone) should be first-line treatment  
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(4). Although nonpharmacological nursing care may be as critical in decreasing withdrawal symptoms 
in infants with NAS, to date no research has focused on the barriers and enablers to nurses’ 
implementation of nonpharmacological nursing interventions for this vulnerable patient population.  
     A preliminary integrative review of factors influencing healthcare providers’ behaviors in the care of 
infants with NAS revealed that the inclusion of nonpharmacologic nursing interventions, refinement of 
NAS assessment skills, and accurate scoring of NAS withdrawal symptoms significantly reduced the 
severity of withdrawal, length of treatment (LOT), and length of stay (LOS), and improved maternal and 
infant outcomes (5-7). In contrast, ineffective nursing interventions, inaccurate assessments, and 
insufficient utilization of abstinence scoring tools contribute to unnecessary pharmacologic treatment, 
which prolongs drug exposure and hospitalization to the possible detriment of maternal-infant bonding 
(8).  
     Because nonpharmacologic nursing care is not complicated by potentially harmful side effects of 
pharmacological treatment, it should be considered the standard of care for opioid-exposed infants (9). 
Nonpharmacologic nursing care consists of the careful assessment of mother and infant, provision of 
caregiving interventions, and the adaptability of environmental and social interactions that support 
neurodevelopment and physiological stability (9). Mitigating the clinical complications of NAS may 
improve outcomes such as withdrawal severity, LOT, and LOS, and those that are more challenging to 
measure, including maternal attachment (10). Further, decreasing NAS infants’ LOS by 2 days could 
result in nationwide savings of an estimated $170 million in hospital charges per year (11).  
     The purpose of this parallel convergent mixed methods study is to investigate barriers and 
enablers to nurses’ implementation of nonpharmacological interventions for infants with NAS 
through the lens of the Theoretical Domains Framework. 
Aim #1:  To explore nurses’ perceptions of barriers and enablers to implementation of 
nonpharmacological nursing interventions for infants with NAS using a descriptive qualitative 
approach.  
 a)  Conduct semi-structured interviews with up to 20 experienced Neonatal Intensive Care Unit  
  (NICU) nurses who care for infants with NAS. 
b) Perform directed content analysis of the interviews, using the TDF as a coding framework to 
 identify specific themes. 
Aim #2: To measure nurses’ perceptions of barriers and enablers to implementation of 
nonpharmacological nursing interventions for infants with NAS using a tailored Determinants of 
Implementation Behavior Questionnaire (DIBQ-NAS).  
 a) Administer the DIBQ-NAS to members (n = 367) of the National Association of Neonatal Nurses 
 (NANN) utilizing the NANN Listservs resource. 
Aim #3: To merge the interview and DIBQ-NAS results to identify and prioritize barriers and 
enablers to inform future implementation of nonpharmacological nursing interventions for 
infants with NAS. 
 
Impact 
     The findings will inform the future development of educational programs for nurses aimed at 
facilitating the implementation of nonpharmacological nursing interventions to improve the care of this 




B.1. The NAS burden to the healthcare system and individuals has reached epidemic 
proportions.  
      
     This study addresses the gap in research on the barriers and enablers to nurses’ implementation of 
nonpharmacological nursing interventions aimed at reducing NAS infants’ withdrawal severity and 
decreasing infants’ LOT and LOS. From 2009 to 2012, NAS incidence increased nationally from 3.4 to 
5.8 per 1000 hospital births, reaching a total of 21,732 infants with the diagnosis (3,11). During the 
same time period, the aggregate hospital costs attributed to the care of infants with NAS increased from 
$732 million to $1.5 billion (11). In addition, admissions of infants with NAS to NICUs increased from 7 
to 27/1000 between 2004 and 2013, with an associated increase in the LOS from 13 to 19 days (12). If  
117 
 
APPENDIX M. – Protocol for Manuscript 3 (continued) 
 
pharmacologic treatment was required, the LOS increased to an average of 23 days (11). Evidence has 
shown that prolonged hospitalization separates the mother from her infant and impairs bonding, an 
impairment associated with negative developmental and behavioral outcomes (13).  
 
     On a global level, this epidemic significantly impacts healthcare systems, as studies have shown in-
utero exposure to opioids is associated with intrauterine growth restriction, congenital anomalies, 
prematurity, low birth weight, and NAS (14). In the US, the federal government promoted the 2015 
Protecting Our Infants Act (S.799), with the objectives of improving NAS surveillance programs, 
addressing research gaps, and implementing effective measures for education, prevention, and 
treatment (15). The US Department of Health and Human Services determined that gaps in research 
were related to “the most appropriate treatment and management of infants with NAS” (S.799). This 
study is designed to inform the future development of educational programs for nurses focused on the 
implementation of nonpharmacological nursing interventions. Developing educational programs for 
nurses will aid in establishing a knowledge base that aligns with several objectives of the Protecting 
Our Infants Act (S.799). 
   
B.2. The implementation of standardized protocols for NAS management is associated with 
decreased LOS and hospital costs (16,17).  
 
     The American Academy of Pediatrics (AAP) Committee on Drugs recommends the establishment of 
an evidence-based protocol guiding the assessment and management of infants diagnosed with NAS 
or those at high risk for withdrawal (8). Although current NAS screening, assessment, and treatment 
methods have limitations, the AAP committee suggests all clinicians be educated on the utilization of 
published withdrawal assessment tools (8). However, the assessment and care management of infants 
with NAS varies widely among hospitals in the US, and existing protocols have been based on minimal 
empirical data (18). In a recent survey of accredited US neonatology fellowship programs, only 55% 
had implemented a written NAS management protocol, and only 69% used a published abstinence 
scoring system to determine the severity of withdrawal and inform the treatment provided (19).  
 
     In addition, new research findings are often not disseminated to clinicians and therefore not 
implemented into practice (20). As a result, infants may not receive the recommended course of 
treatment and may instead receive unnecessary, ineffective, or even harmful therapies (20). This study 
will identify barriers and enablers to nurses’ implementation of nonpharmacological nursing 
interventions, such as NAS management protocols, which have been shown to reduce withdrawal 
severity, LOT, LOS, and hospital costs while improving the care of this vulnerable and rapidly-growing 
patient population (16,17). 
 
B.3. Experts recommend treating the maternal-infant dyad as the standard of care as opposed 
to treating the infant with NAS alone (21-23).  
      
     The nurse’s role is to properly assess and interpret the infant’s behaviors, determine how the mother 
understands and responds to her infant, and tailor interventions that help the mother care for her infant 
(9). However, even though they are well-positioned to have a positive influence on the maternal-infant 
dyad, nurses often exhibit judgmental behaviors because of negative stereotypes about opioid-
dependent mothers (9). In addition, maternal feelings of fear, guilt, and shame related to drug use often 
limit the mother’s ability to have honest conversations with nurses (24). Recent evidence indicates that 
nurses often lack the required knowledge to provide optimal care to the maternal-infant dyad, a barrier 
that may also limit the development of nurse-mother relationships (25). To address these problems, 
research suggests nurses providing care for infants with NAS should receive specialized training that 
addresses all facets of nursing care, including detailed information on adult addiction and drug use 
during pregnancy, maternal attachment behaviors, encouragement of appropriate maternal behavior, 
and breastfeeding when appropriate (24,26). This study is significant as the findings can inform the 
future development of specialized educational programs for nurses focused on the implementation of 
nonpharmacological nursing interventions, such as supporting breastfeeding when appropriate, caring 
for the maternal-infant dyad, and promoting nurse-mother relationships, factors that have been shown 
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C. INNOVATION 
   
     This mixed methods study is innovative because it is the first to investigate barriers and enablers to 
nurses’ implementation of nonpharmacological interventions for infants with NAS. The utilization of a 
mixed methods approach, that includes the administration of a tailored Determinants of Implementation 
Behavior Questionnaire (DIBQ-NAS) to members of NANN, will allow the investigator to gain a 
comprehensive perspective of the barriers and enablers to nurses’ implementation of 
nonpharmacological interventions for infants with NAS. A second source of innovation is that this study 
will be the first to utilize the Theoretical Domains Framework (TDF) to guide the exploration of certain 
behavioral constructs of nurses’ implementation of nonpharmacological nursing interventions for infants 
with NAS. The TDF provides a structure for assessing and evaluating the factors that affect the 
behavior of healthcare providers and the implementation of evidence-based practice (28, 29).  
 
     The results of the interviews and DIBQ-NAS will be merged to identify and prioritize barriers and 
enablers to nurses’ implementation of nonpharmacological interventions for infants with NAS. 
Understanding these factors will aid in the development of specialized educational programs for nurses, 
which will include all facets of nursing care for the NAS maternal-infant dyad to improve the care and 
outcomes of this vulnerable and rapidly-growing patient population. This research is critical to 
establishing a deeper, richer knowledge of the NAS maternal-infant dyad and the nurses who care for 
this complex patient population. 
 
D. GUIDING THEORETICAL FRAMEWORK 
 
       The developers of the TDF identified 33 theories and 128 key theoretical constructs associated 
with behavior change and synthesized them into one framework that can be used to guide theoretical 
assessment of implementation problems, as well as professional and other health-related behaviors as 
a basis for intervention development (28). Knowledge, Skills, and Social/Professional Role and Identity 
were previously identified as the most influential domains relevant to providers’ implementation of 
nonpharmacological interventions aimed at decreasing the LOS for infants with NAS (30). The 
Knowledge domain of the TDF includes the following constructs: knowledge, knowledge about 
condition/scientific rationale, schemas + mindsets + illness representations, and procedural knowledge 
(31). The Skills domain of the TDF includes the following constructs: skills, competence/ability/skill, 
assessment, practice/skills development, interpersonal skills, and coping strategies (31). The 
Social/Professional Role and Identity domain of the TDF includes the following constructs: identity, 
professional identity/boundaries, role, group/social identity, social/group norms, and 
alienation/organizational commitment (31). In the preliminary integrative review, the primary themes 
identified within these domains included: knowledge of NAS and AAP recommendations regarding the 
management of NAS, nursing competence (assessment skills and effective utilization of the Finnegan 
scoring tool), development of interpersonal relationships with parents within professional boundaries, 
establishment of role within a multidisciplinary team, and leadership in the management and care of 
infants with NAS. In addition to the Knowledge, Skills, and Social/Professional Role and Identity 
domains, this study will investigate other influential contextual and environmental domains related to 
infants with NAS and the nurses that care for the NAS maternal-infant dyad.  
 
E. DIVERSITY AND SOCIAL DETERMINANTS OF HEALTH 
 
     The intent of this study is to obtain a diverse sample of participants with regard to nurses’ gender, 
age, race/ethnicity, level of education and nursing experience. The patient population being served by 
this study, the maternal-infant dyad, has experienced changes over the past several years with regard 
to race and ethnicity. A recent study showed an increasing proportion of mothers of white race (from 
64% in 2004-2005 to 76% in 2012-2013) and a corresponding decrease during the study period in the 
proportions of mothers of black race and Hispanic ethnic group (p<.001) (12). However, the study also 
showed no significant changes in maternal age, gravidity, parity, or percentage of mothers who 
received prenatal care from 2005-2005 to 2012-2013 (12). In addition, the pattern of opioid use has 
shifted from an inner-city, low-income population to a more socioeconomically and demographically  
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diverse population that includes pregnant women (32,33). Findings from recent research highlight the 
critical need to understand the significant increase in healthcare utilization and clinical treatment of 
infants with NAS in order to define research priorities and design public health programs to improve 
healthcare delivery for the infants and their mothers (12). The findings from this study will inform future 
development of specialized educational programs for nurses focused on caring for the maternal-infant 
dyad and promoting nurse-mother relationships, factors that have been shown not only to enhance 
maternal self-efficacy but also to address stigmatization, a Social Determinant of Health, of the NAS 
maternal-infant dyad by healthcare providers (34). Further, specialized education for mothers of infants 
with NAS provided by nurses is an additional Social Determinant of Health to be addressed in this 




F.1. Preliminary Studies 
     The principal investigator (PI) is currently completing a small pilot study to explore how nurses and 
other key interdisciplinary team members perceive the treatment plan and care provided for infants with 
NAS. The findings from the pilot study will be used to inform and further refine the research design and 
methods for this study. In preparation for this study, the PI completed an integrative review, guided by 
the constructs of the TDF, which focused on factors influencing healthcare providers’ behaviors in the 
care of infants with NAS. Knowledge, Skills, and Social/Professional Role and Identity were the most 
influential domains relevant to modifying healthcare providers’ behaviors surrounding implementation of 
nonpharmacological interventions aimed at decreasing the LOS for infants with NAS. 
 
F.2. Design Overview 
     This convergent parallel mixed methods study will be conducted through the lens of the TDF. The 
concurrent timing of quantitative and qualitative strands will allow the PI to equally prioritize each 
method and utilize two independent forms of data, allowing for greater insight into the phenomena. 
Quantitative data collection will involve participants’ completion of a DIBQ-NAS that measures nurses’ 
perceptions of barriers and enablers to implementation of nonpharmacological nursing interventions for 
infants with NAS. In addition, descriptive data from quantitative and qualitative study participants will be 
collected through brief demographic surveys. Semi-structured interviews will be conducted to provide 
qualitative data for thematic analysis to describe nurses’ perceptions of barriers and enablers to 
implementation of nonpharmacologic nursing interventions for infants with NAS. The merging of the 
interview and DIBQ-NAS results will allow for the identification and prioritization of barriers and 
enablers to inform future implementation of nonpharmacological nursing interventions for infants with 
NAS.  
 
F.3. Mixed-Methods Methodology 
      
     For the purposes of presenting the research design and methods, each one of the three 
individual aims will be presented individually. 
 
Aim #1:  To explore nurses’ perceptions of barriers and enablers to implementation of 
nonpharmacological nursing interventions for infants with NAS using a descriptive qualitative 
approach.  
 
     Introduction: Semi-structured, individual interviews using open-ended questions will be conducted 
to explore nurses’ perceptions of barriers and enablers to caring for infants with NAS. The PI will 
request a waiver of signed consent from the Institutional Review Board (IRB) at MUSC. Prior to each 
participant’s inclusion in the study, the PI will explain the full details of the interview procedures as well 
as the risks involved. Participants will also be informed that they are free to withdraw from the study at 
any time. Before protocol-specific procedures commence, the PI will explain the aspects of healthcare 
provider privacy concerning research specific information. Each participant and consenting professional 
will receive an information sheet regarding the study via email prior to the interview. At the beginning of 
the interview, the PI will deliver detailed verbal instructions regarding the demographic survey and 
interview. The PI will ask 8 open-ended questions with probes using an interview guide. Completion of 
the demographic survey and interview will take approximately 45 minutes. 
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     Study participants will be recruited from the Level 2 Neonatal Nursery of the NICU at MUSC. The 
NICU at MUSC currently employs over 200 nurses and is a state-designated regional perinatal center, 
providing comprehensive care to healthy and critically ill newborns throughout the state. Each year 
approximately 2,000 newborns are delivered at MUSC, and an additional 12,000 babies are born within 
MUSC’s referral area. These deliveries generate approximately 900 admissions to the intensive care 





     Purposeful sampling will be used to recruit participants who have experience caring for infants with 
NAS and their families. The intent will be to obtain a diverse sample of participants with regard to 
gender, age, race/ethnicity, and level of education and nursing experience. 
  
     The PI will recruit up to 20 participants for interviews until theoretical saturation is achieved. 
Theoretical saturation is the point at which no new information emerges in the data (35). The PI will 
recruit nurses who have at least 6 months of experience caring for infants diagnosed with NAS (see 
Table 1). The demographic surveys and interviews will be conducted in person, in a private conference 
room located in the Children’s Hospital at MUSC, or via phone or videoconference according to 
participants’ preference. Interview participants will be recruited from the Level 2 Neonatal Nursery of 
the NICU and members of NANN who have completed the DIBQ-NAS and selected the option to 
participate in an interview.  
 
Table 1 – Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
 
• Nurses must be licensed and registered to 
practice in their state. 
• Nurses whose primary NAS experience is 
related to infants withdrawing from 
opioids/sedatives because the infant is on 
mechanical ventilation. The type of NAS 
experience will be evaluated by the PI during the 
participant screening process. 
• For participants recruited from the Level 2 
Neonatal Nursery of the NICU at MUSC, nurses 
must have at least 6 months’ experience caring 
for infants with NAS. 
 
 
F.6. Eligibility and Recruitment 
 
     Nurses who have at least 6 months’ experience caring for infants diagnosed with NAS will be invited 
to participate in this study. For Level 2 Neonatal Nursery nurses, invitations to participate will be 
extended via employee group emails, flyers located in staff areas, and monthly staff meetings. After a 
nurse has expressed interest in participating by emailing or calling the PI, the PI will contact the 
potential participant, briefly describe the study, and screen for eligibility. Once the nurse is determined 
to be eligible, the PI will proceed with enrollment in the study. Additional interview participants will be 
recruited to complete the DIBQ-NAS. Members of NANN will indicate their willingness to participate in a 
phone or videoconference interview with the PI by selecting an option at the end of the questionnaire. 
The PI will be notified via REDCap of a participant’s interest in completing an interview. The PI will 
contact the interested member via email or phone to complete the eligibility screening process.   
Pending study funding, interview participants will be entered into a drawing to receive 1 of 2 $25 gift 
cards. 
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     Demographic information on gender, age, race/ethnicity, and level of education and nursing 
experience will be collected from the participants (Appendix 1). Approximately 20 Semi-structured, 
individual interviews will be conducted in a private conference room at the Children’s Hospital at MUSC, 
or via phone or videoconference according to participants’ preference, with the investigator utilizing an 
interview guide (Appendix 2). Open-ended interview questions will explore nurses’ perceptions of 
barriers and enablers to implementation of nonpharmacological nursing interventions for infants with 
NAS (Appendix 2). The interview guide is designed to yield information related to nurses’ perceptions 
and experiences with caring for infants with NAS; factors they believe impact the infant’s length of stay; 
efficacy and effectiveness of withdrawal scoring instruments; and nurses’ perceptions of mothers’ 
responses and interactions with her infant. All interviews will be audio recorded, transcribed using an 
MUSC-approved transcription service, and entered into NVivo12 software for coding and analysis. 
 
F.8. Data Analysis 
 
     The PI will collect data from a number of sources to address the study aims. Interview transcripts will 
be compared against original recordings to ensure accuracy. Data from participant interviews will be 
analyzed using conventional content analysis and NVivo12 qualitative data analysis software to code 
data into common themes. With the TDF as an initial coding framework, the PI will use the constant-
comparative method throughout the process of data analysis until theoretical saturation has occurred. 
The expected outcome of qualitative descriptive studies is a straight, descriptive summary of 
informational contents of data organized in a way that best fits the data (chronologically by topic, by 
relevance, etc.) (36). Analytic strategies include: a) coding of data from notes or interviews b) recording 
insights and reflections on the data c) sorting through the data to identify similar phrases, patterns, 
themes, sequences, or important features d) looking for commonalities and differences among the data 
and extracting them for further consideration and analysis e) gradually deciding on a small group or 
generalizations that hold true for the data f) examining these generalizations in the light of existing 
knowledge (37). 
 
     Data from the demographic surveys will be stored within REDCap and exported to SPSSv22 for 
analyses. Descriptive statistics will be used to provide basic information about the variables in the 
dataset and highlight potential relationships between the quantitative and qualitative samples. 
Descriptive statistics such as, frequency distributions, measures of central tendency (mean, median), 
and measures of dispersion or variation will be computed on the demographic characteristics (gender, 
age, race/ethnicity, and level of education and nursing experience) and of the study participants. 
 
Aim #2: To measure nurses’ perceptions of barriers and enablers to implementation of 
nonpharmacological nursing interventions for infants with NAS using a tailored Determinants of 
Implementation Behavior Questionnaire (DIBQ-NAS).  
 
     Introduction: We expect that the demographic survey and DIBQ-NAS will be completed by 
approximately 400 members of NANN, an approximate response rate of 22%, over the course of 4-6 
months. For a 95% confidence interval with a standard deviation of 0.5 and ± 5% margin of error, 367 
members of NANN will be needed based on an approximate membership of NANN of 8200 (38). A link 
to the demographic survey and DIBQ-NAS, administered through REDCap via email, will be sent to the 
entire membership of NANN; however, initial questionnaire screening will likely reduce the study 
sample to those who have at least 6 months of experience caring for infants with NAS. A screen, prior 
to navigating to the surveys, will allow the member to consent to participating in the study. The 




     Study participants will be recruited through NANN, a professional organization of registered nursing 
professionals at all stages of their careers who care for newborn infants born with a variety of health 
challenges, including prematurity, birth defects, infection, cardiac malformations, and surgical problems. 
In addition, participants enrolled in the quantitative component (Aim #2) will have the opportunity to 
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A database will be developed in REDCap that will include a demographic survey and the DIBQ-NAS. 
The link to the demographic survey and DIBQ-NAS will be sent via email to more than 8,200 members 
of NANN using the NANN Listservs resource. Approximately 367 NANN members will be needed to 
complete the survey given a 95% confidence interval with a standard deviation of 0.5 and ± 5% margin 
of error (confidence interval) (38). Additional interview participants for Aim #1 will be recruited through 
the REDCap survey by providing the interested member the option to participate in an interview. 
 
Table 2 – Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
 
Nurses must be members of NANN, self-report 
having at least 6 months’ experience caring for 
infants with NAS, and have access to a computer 
with a valid email address (for purposes of 
completing survey instrument via REDCap). 
 
 
F.11. Eligibility and Recruitment 
 
Members of NANN will be sent a demographic survey and DIBQ-NAS, administered through REDCap 
via email, requesting participation by completing the surveys. While there are over 8200 members of 
NANN currently, the PI will aim to collect data from approximately 367 completed surveys (see Table 
2). The DIBQ-NAS will conclude with an option for nurses to express interest in completing a telephone 
interview with the PI. Pending study funding, participants completing the DIBQ-NAS will be entered into 
a drawing to receive 1 of 6 $25 gift cards. 
 
F.12. Data Collection 
      
     To design effective strategies to improve nurses’ implementation behaviors, a valid and reliable 
questionnaire is needed to assess potential implementation determinants (39). The DIBQ was 
developed to measure the potential behavior determinants of the 12-domain version of the TDF (40). 
The initial DIBQ contained 100 items assessing 12 domains. Results obtained from confirmatory factor 
analysis and Cronbach’s alpha resulted in the DIBQ consisting of 93 items assessing 18 domains, 
explaining 63.3% of the variance, and internal consistency reliability values ranging from .68 to .93. 
Domains demonstrated good discriminant validity, although the domains Knowledge and Skills, and 
domains Skills and Social/professional Role and identity were highly correlated. The DIBQ, although 
thorough, is long and tedious and may deter potential participants from completing it. 
  
     The PI will utilize a tailored, more succinct version of the DIBQ (Appendix 3) in the proposed study. 
The tailoring of the DIBQ will be completed by the PI and informed by findings from the integrative 
review in which Knowledge, Skills, and Social/Professional Role and Identity were identified as the 
most influential domains relevant to modifying healthcare providers’ behaviors regarding the 
implementation of nonpharmacological interventions aimed at decreasing the LOS for infants with NAS. 
However, in addition to these 3 domains, other influential contextual and environmental domains will be 
incorporated into the tailored version of the DIBQ. The original developers of the DIBQ designed the 
questionnaire to be easily adaptable so it can be used in studies investigating implementation 
behaviors performed by other healthcare providers in other settings (39). The DIBQ-NAS will consist of 
11 questions pertaining to the Knowledge, Skills, Organizational Resources and Support, Innovation 
Strategies, Perceive Behavioral Control, and Social Support of nurses who care for infants with NAS 
and their families. The DIBQ-NAS will utilize an ordinal scale to approximate interval properties, such 
as Likert-type responses to measure nurses’ perceptions regarding implementation of 
nonpharmacological nursing interventions for the infants with NAS. A consistent variable coding 
strategy will be developed for item responses where lower values represent less confidence/agreement 
and higher values represent greater confidence/agreement. The DIBQ-NAS is designed to yield 
information related to the influential constructs and domains of the TDF relevant to modifying nurses’  
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behaviors regarding the implementation of nonpharmacological interventions aimed at decreasing the 
LOS for infants with NAS. 
 
F.13. Data Analysis 
 
     Rigorous quantitative data analysis procedures will include: a) preparing the data for analysis b) 
exploring the data c) validate the tailored questionnaire d) analyzing the data e) representing the data 
analysis f) interpreting the results and g) validating the data and results (41).  
 
     The PI will conduct an exploratory factor analysis (EFA) on the DIBQ-NAS to empirically identify 
dimensionality of the TDF Constructs (Knowledge, Skills, Organizational Resources and Support, 
Innovation Strategies, Perceive Behavioral Control, and Social Support) utilized in the DIBQ-NAS. The 
first phase of the EFA will involve transforming the raw data matrix into a correlation matrix to ensure it 
is factorable, to determine if there are missing data problems that need to be resolved, implement mean 
or median item imputation if required, and to ascertain that the sample size is adequate (42). The next 
phase will include identifying the appropriate extraction method (i.e., maximum likelihood) to determine 
the number of factors needed to adequately capture the variance in the set of variables (43). The third 
phase includes determining how many factors to retain. This phase will likely include the use of oblique 
rotation (i.e., direct oblimin), scree plots, and multiple test runs to determine how many meaningful 
factors will be in a data set (43). The fourth phase includes determining the method of rotation to 
transform the original factors so that the results are more interpretable. The final phase will involve 
interpreting, evaluation, and refining the factors (43). 
 
     Preparing the data for analysis will include cleaning data entry errors from the database, and 
implementing appropriate data analysis procedures when applicable, such as mean or median item 
imputation, depending on the importance and pattern of the missing data. Exploring the data involves 
visually inspecting the data and conducting a descriptive analysis (the mean, standard deviation, and 
variance of responses to each item on the instrument) to determine the general trends in the data. 
Analyzing the data will involve choosing the appropriate statistical test; analyzing the data to answer the 
research questions, report inferential test, effect sizes, and confidence intervals: and using quantitative 
statistical software (SPSSv22) programs (41). 
 
     In addition, assuming normal distribution, the PI will conduct an analysis of variance (ANOVA), a 
bivariate parametric test, to draw inferences about differences among the study participants and to 
determine construct validity of the DIBQ-NAS. However, when comparing only two groups (i.e., gender) 
the t-test will be used. The independent variables are the demographic characteristics of the 
participants (i.e., gender, age, race, and level of education and nursing experience), and the dependent 
variables are the domains and constructs of the TDF (i.e. Knowledge, Skills, Organizational Resources 
and Support, Innovation Strategies, Perceive Behavioral Control, and Social Support) as they relate to 
nurses who care for infants with NAS and their families. Further, the PI will conduct chi-square tests to 
determine inferences regarding the relationship between categorical variables. If the sample size is too 
small, or determining if the proportions of one variable are different depending on the value of the other 
variable, a Fisher’s exact test will be utilized. 
 
     Data from the DIBQ-NAS and the demographic surveys will be stored within REDCap and exported 
to SPSSv22 for analyses. In addition, demographic data collected during interviews will be manually 
entered into REDCap and exported to SPSSv22 for analyses. Descriptive statistics will be used to 
provide basic information about the variables in the dataset and highlight potential relationships 
between the quantitative and qualitative samples. Descriptive statistics such as, frequency distributions, 
measures of central tendency (mean, median), and measures of dispersion or variation will be 
computed on the demographic characteristics (gender, age, race/ethnicity, and level of education and 
nursing experience) and of the study participants. 
 
     The intent is to understand clinical and demographic characteristics of the participants and the 
constructs of the TDF as they relate to the implementation of nonpharmacological nursing interventions 
for infants with NAS.     
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Aim #3: To merge the interview and DIBQ-NAS results to identify and prioritize barriers and 
enablers to inform future implementation of nonpharmacological nursing interventions for 
infants with NAS. 
 
F.14. Data Collection 
 
     The findings from the demographic surveys, interviews (from Level 2 Neonatal Nursery nurses and 
NANN participants), and DIBQ-NASs will be merged and analyzed. It is expected the results will allow 
the PI to identify and prioritize barriers and enablers to inform future development of educational 
programs for nurses aimed to facilitate implementation of nonpharmacological nursing interventions to 
improve the care of the NAS maternal-infant dyad. 
 
F.15. Data Analysis 
 
     The results from Aim #1 and Aim #2 will be merged. Data merging involves the joint review of both 
data types to compare and contrast themes. The data for Aim #1 and Aim #2 will be collected 
concurrently; however, the data will be independently analyzed using analytic approaches best suited 
to the quantitative and qualitative research questions (Figure 2). A joint display will be the strategy used 
to array both quantitative and qualitative data so that the two sources of data can be directly compared. 
The themes that emerge from the quantitative and qualitative data will be categorized utilizing the 
domains and constructs of the TDF.  
 
Figure 2: Data Analysis of Convergent Parallel Design
  
F.16. Potential Problems and Alternative Strategies 
 
     This study has the potential to be affected by challenges such as inadequate sample size, inability to 
coordinate interviews due to work schedules, participant fatigue, and erroneous data. In addition, there 
is the potential for social desirability response bias (44) to exist, where participants answer questions 
with a response they feel is more socially acceptable. To mitigate these challenges, the PI will provide 
an introduction to the study and extend invitations to participate via multiple venues, such as employee 
group emails, flyers located in staff areas, monthly staff meetings, and the NANN Listservs database. In 
addition, the PI will schedule the demographic surveys and interviews at the convenience of the 
participant, to be completed in person, in a private conference room located in the Children’s Hospital 
at MUSC, or via phone or videoconference according to participants’ preference. The PI will protect 
participants against financial risks by carefully scheduling interviews so that work is not interrupted. In 
addition, the interviews will take approximately 45 minutes to complete and the DIBQ-NAS will take 
approximately 10 minutes to complete to avoid participant fatigue. The PI will also employ the strategy 
of creating rapport with the participants, using a comfortable environment conducive to interviews, and 
educating the participant about the study and how the information collected will be used (44). By 
mentioning that there is no right or wrong answer and that the data will be carefully secured, the PI will 
also give participants permission to respond honestly (44). To mitigate the incorporation of incomplete 
or missing data from the DIBQ-NAS, which may skew results, the PI will implement appropriate data  
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analysis procedures when applicable, such as mean or median item imputation, depending on the 




     Table 3 includes the anticipated timeline for completing the primary objectives for the proposed 
study: IRB approval, participant recruitment, data collection, data analysis, manuscript preparation, and 
submit for publishing. Aim #1 and #2 will be conducted concurrently. 
 
Table 3 – Proposed Study Timeline 
Primary Objectives Anticipated Date of Completion 
 
• Obtain IRB approval for proposed study • 6/2018 – 7/2018 
• Participant recruitment • 8/2018 – 1/2019 
• Data collection • 8/2018 – 1/2019 
• Data analysis • 8/2018 – 1/2019 
• Manuscript preparation • 2/2019 – 3/2019 
• Submit compendium • 4/2019 
 
G. Human Subjects 
 
G.1. Risk to the Subjects 
 
a. Human Subjects Involvement and Characteristics 
 
     Study participants for Aim #1 will be recruited from the Level 2 Neonatal Nursery of the NICU at 
MUSC. The NICU at MUSC currently employs over 200 nurses and is a state-designated regional 
perinatal center, providing comprehensive care to healthy and critically ill newborns throughout the 
state.  
      
     Purposeful sampling will be used to recruit participants who have experience caring for infants with 
NAS and their families. The intent will be to obtain a diverse sample of participants with regard to 
gender, age, race/ethnicity, level of education, and nursing experience. For this study, the PI will 
attempt to recruit up to 20 participants for interviews until theoretical saturation is achieved. The PI will 
recruit nurses who have at least 6 months of experience caring for infants diagnosed with NAS (Table 
1). The interviews will be conducted in person, in a private conference room located in the Children’s 
Hospital at MUSC, or via phone or videoconference according to participants’ preference. 
 
     For Aim #2, participants will be recruited through NANN, a professional organization of registered 
nursing professionals at all stages of their careers who care for newborn infants born with a variety of 
health challenges, including prematurity, birth defects, infection, cardiac malformations, and surgical 
problems. Interview participants will be recruited from the Level 2 Neonatal Nursery of the NICU and 
members of NANN who have completed the DIBQ-NAS and selected the option to participate in an 
interview.  
 
     A survey conducted by the National Council of State Board of Nursing (NCSBN) in 2015 indicated 
that of US nurses, 14.1% were male, 19.5% identified themselves as a racial/ethnic minority, 42% had 
a bachelor of science in nursing (BSN) as their initial credential, while 65% obtained a baccalaureate or 
higher degree (in any field) as their highest level of education (45). The intent of this study is to obtain a 
diverse sample of participants with regard to nurses’ gender, age, race/ethnicity, and level of education 
and nursing experience. The targeted enrollment for this study is representative of the demographics of 
US nurses identified in the 2015 NCSBN survey. 
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Targeted/Planned Enrollment Table: Nurses 
 
    Total Planned Enrollment: 387 Participants 
 
TARGETED/PLANNED ENROLLMENT: Number of Subjects 
Ethnic Category 
Sex/Gender 
Females Males Total 
Hispanic or Latino 6 3 9 
Not Hispanic or Latino 326 52 378 
Ethnic Category: Total of All Subjects* 332 55 387 
Racial Categories  
American Indian/Alaska Native 0 0 0 
Asian 20 3 23 
Native Hawaiian or Other Pacific Islander 0 0 0 
Black or African American 33 5 38 
White 273 44 317 
Racial Categories: Total of All Subjects* 326 52 378 
 
Inclusion of Women and Minorities 
      
     Both women and minorities will be included in the proposed study. However, the Level 2 Neonatal 
Nursery at MUSC (recruitment site for Aim #1) currently employs 2 male White nurses and 4 female 
African American nurses. The intent for Aim #2 is to gain participant diversification and minority 
participation through the use of the NANN membership Listservs database. 
 
b. Sources of Materials 
       
     The only sources of research-related information obtained from human subjects are described in the 
above research proposal. Data sources include:  
  • Audio recordings, transcriptions, and field notes from interviews. 
  • De-identified electronic data from survey information recorded in REDCap. 
     All data will be used specifically for research purposes. Every effort will be made to keep study 
records confidential. No identifiers will be used in any reports or publications resulting from this study; 
however, the data may be used in future studies. 
 
c. Potential Risks 
  
     Although we do not expect any significant risks related to the completion of the surveys and 
interviews in this study, it is possible a participant may experience emotional distress while completing 
the survey and interview. If necessary, protection against psychological or emotional distress will be 
provided through debriefing sessions following interviews. In the case of psychological or emotional 
distress that is not relieved by debriefing, the PI will arrange a referral to a psychologist or psychiatrist. 
In addition, the participant may choose to discontinue participating in the study at any time. The PI 
conducting the interviews will monitor the participant for signs of distress and appropriate follow-up will 
be provided to identify any serious psychological concerns. In the event of a life-threatening 
emergency, the investigator will call 911. 
 
G.2. Adequacy of Protections Against Risks 
 
a. Recruitment and Informed Consent 
 
     For Aim #1, registered nurses who have at least 6 months’ experience caring for infants diagnosed 
with NAS will be invited to participate in this study. For Level 2 Neonatal Nursery nurses, invitations to 
participate will be extended via employee group emails, flyers located in staff areas, and monthly staff 
meetings. Additional interview participants will be recruited through the DIBQ- NAS. Members of NANN 
will indicate their willingness to participate in a phone or videoconference interview with the PI by 
selecting an option at the end of the questionnaire. The PI will be notified via REDCap of a participant’s 
interest in completing an interview. The PI will contact the interested member via email or phone to  
127 
 
APPENDIX M. – Protocol for Manuscript 3 (continued) 
 
complete the eligibility screening process. Interview participants will be enrolled on a first come, first 
served method. 
 
     For Aim #2, registered nurses who have at least 6 months’ experience caring for infants diagnosed 
with NAS and have access to a computer with a valid email address will be invited to participate in this 
study. Participants will be recruited through NANN using the Listservs resource. Members of NANN will 
be sent a demographic survey and DIBQ-NAS, administered through REDCap via email, requesting 
participation by completing the surveys. The DIBQ-NAS will conclude with an option for nurses to 
express interest in completing a telephone interview with the PI. 
 
     The PI will seek a waiver of signed consent, since no interventions are being performed. The 
Information for Interview/Survey Participants document (see Appendix 4 and 5, respectively) will be 
provided to participants and will describe the study objectives and contain all other required elements of 
consent. The document also notes what topics will be discussed, how long the survey/interview process 
should take to complete, and assurance of confidentiality. The PI has received adequate training in 
human subject protections, including Miami CITI training. Prior to their inclusion in the study, 
participants will be informed about the details of the study procedures and protocol as well as the risks 
involved with participating. Participants will also be informed that they are free to withdraw from the 
study at any time.  
 
     For interview participants, before protocol-specific procedures commence, the PI will fully explain 
the aspects of healthcare provider privacy concerning research specific information. Each participant 
and consenting professional will receive an information sheet regarding the study. For participants 
completing the DIBA-NAS, the first screen of the survey will include the study information for 
participants and they can select the option to continue to the survey or disagree to exit the survey. All 
participants will be reminded that every effort will be made to maintain their confidentiality and that they 
may refuse to participate in the study or withdraw at any time without explanation, and that such an 
action will in no way affect their status as an employee of MUSC and/or membership with NANN.  
 
b. Protection Against Risk and Data Management 
 
     Minimal risk is anticipated for this proposed study. In the event of an unexpected event as a result of 
participating in the surveys and/or interviews, the participant will be instructed to contact the PI. Based 
on the study design, it is anticipated that the risk of adverse events (AE) will be acceptably low to non-
existent. However, in the event of an AE, it will be recorded and reported to the IRB and investigator 
according to institutional requirements and procedures. The PI’s doctoral advisor will review all AEs.  
         
     Several plans are in place for protection of participant confidentiality. The Information for 
Interview/Survey Participants document (Appendix 4 and 5) assures confidentiality of all information 
obtained during the study. Confidentiality of participants will be protected by conducting interviews in a 
private location that will be secured by the investigator prior to the scheduled interview. The confidential 
data will be de-identified for transcription and analysis. Each participant will be assigned a case number 
to be referenced on study instruments. The participant identification and enrollment log will also be 
confidential and filed by the PI in the study file. To ensure participant confidentiality, no paper copies 
will be made. All reports and communications related to the study will identify participants by assigned 
case number. All data will be stored in a secure, password-protected REDCap database, in accordance 
with MUSC’s data storage requirements, and the passwords to those files will be accessible to the PI 
and the PI’s doctoral advisor only.  
 
     No personal identifiers will be collected; however, email addresses and telephone numbers may be 
used for the purposes of contacting participants to schedule interviews or to send surveys. Participant 
contact information will not be connected to any data, and it will be discarded after interviews and 
surveys have been completed. Breach of confidentiality may be considered an AE, and will be reported 
to the IRB. 
 
      Audio recordings of interview sessions will be uploaded from a portable recorder to password-
protected MUSC network storage after which the recordings will be deleted from the portable recorder. 
Transcription of audio recorded interviews will be conducted by an MUSC-approved transcription  
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service. The PI will store all transcribed data and study-related documents in a fingerprint-protected 
safe that will only be accessed by authorized personnel. Data obtained during interviews will be stored 
in a locked location, accessible only to the PI and doctoral advisor. In addition, caution will be used 
when presenting interview findings. The intent is to provide adequate quotes and raw data to elicit thick 
descriptions while avoiding unintentional disclosure of participant identity. Digital audio recordings of 
interviews will be stored in a secure electronic database for a minimum of 6 years. 
 
     There are no social or legal risks associated with participating in this study. Significant efforts will be 
undertaken to ensure the safety of all participants. The PI will protect participants against physical risks 
by observing for fatigue and providing breaks when needed. If a participant feels she/he cannot 
continue with the interview, the interview session will be rescheduled. Participants will be protected 
against financial risks by scheduling interviews so that work is not interrupted. In the event of study-
related illness or injury, participants will be instructed on how to access health care. Participants will be 
given an information sheet with the PI’s name and phone number to contact in the event that there is a 
problem or if the participant has study-related questions. 
   
G.3. Potential Benefits of the Research to Subjects and Others 
 
     Participants will receive no direct benefit from the study. However, the disclosures of the participants 
will inform future development of educational programs for nurses aimed at facilitating the 
implementation of nonpharmacological nursing interventions to improve the care of the NAS maternal-
infant dyad. The benefits outweigh the potential inconvenience to the participants in terms of 
anticipated new knowledge gained from this study. 
 
G.4. Knowledge to be Gained 
 
     The findings from this study will provide valuable information with the purpose of identifying barriers 
and enablers to nurses’ implementation of nonpharmacological nursing interventions. These findings 
will also inform the future development of educational programs for nurses that focus on a) the 
implementation of nonpharmacological nursing interventions, such as, effective infant screening, 
withdrawal assessment, and utilization of abstinence scoring tools and b) adult substance use, caring 
for the maternal-infant dyad, and promoting nurse-mother relationships, all of which have been shown 
to reduce withdrawal severity, LOT, LOS, hospital costs, while enhancing maternal self-efficacy in 
caring for her infant and improving the care of this vulnerable and rapidly-growing patient population. 
 
G.5. Subject Safety and Minimizing Risks (Data and Safety Monitoring Plan) 
 
     The PI will ensure safeguarding of the data through the following actions: 
• Weekly tracking of subject accrual (enrollment, demographics) 
• Timely and appropriate reporting of protocol deviations, privacy breaches, conflicts of interest, 
or changes in personnel 
• Ongoing daily monitoring of secure data storage  
The PI will be responsible for monitoring the study and complying with reporting requirements. The 
mentoring team will meet with the PI bi-weekly to provide oversight to ensure data safeguarding.  
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